diseaseName,class,ald,apc,cancer,deficiency,disease,dmd,dystrophy,muscular,ovarian,syndrome
tumour,Modifier,0,0,0,0,0,0,0,0,0,0
hemochromatosis,Modifier,0,0,0,0,0,0,0,0,0,0
HH,Modifier,0,0,0,0,0,0,0,0,0,0
HH,Modifier,0,0,0,0,0,0,0,0,0,0
HH,Modifier,0,0,0,0,0,0,0,0,0,0
HH,Modifier,0,0,0,0,0,0,0,0,0,0
HH,Modifier,0,0,0,0,0,0,0,0,0,0
ovarian cancer,Modifier,0,0,1.12966,0,0,0,0,0,1.07443,0
breast cancer,Modifier,0,0,1.12966,0,0,0,0,0,0,0
ovarian cancer,Modifier,0,0,1.12966,0,0,0,0,0,1.07443,0
ovarian cancer,Modifier,0,0,1.12966,0,0,0,0,0,1.07443,0
ovarian cancer,Modifier,0,0,1.12966,0,0,0,0,0,1.07443,0
ovarian cancer,Modifier,0,0,1.12966,0,0,0,0,0,1.07443,0
cancer,Modifier,0,0,1.12966,0,0,0,0,0,0,0
ovarian cancer,Modifier,0,0,1.12966,0,0,0,0,0,1.07443,0
ovarian cancer,Modifier,0,0,1.12966,0,0,0,0,0,1.07443,0
absence of functional C7,Modifier,0,0,0,0,0,0,0,0,0,0
dystonic,Modifier,0,0,0,0,0,0,0,0,0,0
FMF,Modifier,0,0,0,0,0,0,0,0,0,0
ALPS,Modifier,0,0,0,0,0,0,0,0,0,0
ALPS,Modifier,0,0,0,0,0,0,0,0,0,0
ALPS,Modifier,0,0,0,0,0,0,0,0,0,0
ALPS,Modifier,0,0,0,0,0,0,0,0,0,0
ALD,Modifier,0,0,0,0,0,0,0,0,0,0
DPD,Modifier,0,0,0,0,0,0,0,0,0,0
HBL,Modifier,0,0,0,0,0,0,0,0,0,0
HBL,Modifier,0,0,0,0,0,0,0,0,0,0
HBL,Modifier,0,0,0,0,0,0,0,0,0,0
HBL,Modifier,0,0,0,0,0,0,0,0,0,0
hemochromatosis,Modifier,0,0,0,0,0,0,0,0,0,0
hemochromatosis,Modifier,0,0,0,0,0,0,0,0,0,0
C2-deficient,Modifier,0,0,0,0,0,0,0,0,0,0
type I C2-deficient,Modifier,0,0,0,0,0,0,0,0,0,0
type II C2-deficient,Modifier,0,0,0,0,0,0,0,0,0,0
C2-deficient,Modifier,0,0,0,0,0,0,0,0,0,0
fragile X,Modifier,0,0,0,0,0,0,0,0,0,0
anxiety,Modifier,0,0,0,0,0,0,0,0,0,0
BPAD,Modifier,0,0,0,0,0,0,0,0,0,0
CHM,Modifier,0,0,0,0,0,0,0,0,0,0
CHM,Modifier,0,0,0,0,0,0,0,0,0,0
CHM,Modifier,0,0,0,0,0,0,0,0,0,0
CHM,Modifier,0,0,0,0,0,0,0,0,0,0
CHM,Modifier,0,0,0,0,0,0,0,0,0,0
CHM,Modifier,0,0,0,0,0,0,0,0,0,0
ALD,Modifier,0,0,0,0,0,0,0,0,0,0
adrenoleukodystrophy,Modifier,0,0,0,0,0,0,1.14098,0,0,0
ALD,Modifier,0,0,0,0,0,0,0,0,0,0
ALD,Modifier,0,0,0,0,0,0,0,0,0,0
ALD,Modifier,0,0,0,0,0,0,0,0,0,0
von Willebrand,Modifier,0,0,0,0,0,0,0,0,0,0
von Willebrand,Modifier,0,0,0,0,0,0,0,0,0,0
breast-ovarian cancer,Modifier,0,0,1.12966,0,0,0,0,0,1.07443,0
breast-ovarian cancer,Modifier,0,0,1.12966,0,0,0,0,0,1.07443,0
breast and ovarian cancer,Modifier,0,0,1.12966,0,0,0,0,0,1.07443,0
Tay-Sachs,Modifier,0,0,0,0,0,0,0,0,0,0
Tay-Sachs disease,Modifier,0,0,0,0,1.22993,0,0,0,0,0
Tay-Sachs disease,Modifier,0,0,0,0,1.22993,0,0,0,0,0
Tay-Sachs disease,Modifier,0,0,0,0,1.22993,0,0,0,0,0
Tay-Sachs disease,Modifier,0,0,0,0,1.22993,0,0,0,0,0
Tay-Sachs disease,Modifier,0,0,0,0,1.22993,0,0,0,0,0
TSD,Modifier,0,0,0,0,0,0,0,0,0,0
TSD,Modifier,0,0,0,0,0,0,0,0,0,0
TSD,Modifier,0,0,0,0,0,0,0,0,0,0
Machado-Joseph disease,Modifier,0,0,0,0,1.22993,0,0,0,0,0
MJD,Modifier,0,0,0,0,0,0,0,0,0,0
MJD,Modifier,0,0,0,0,0,0,0,0,0,0
DMD,Modifier,0,0,0,0,0,0,0,0,0,0
DMD,Modifier,0,0,0,0,0,0,0,0,0,0
DMD,Modifier,0,0,0,0,0,0,0,0,0,0
alkaptonuria,Modifier,0,0,0,0,0,0,0,0,0,0
C9 deficiency,Modifier,0,0,0,1.37377,0,0,0,0,0,0
Lesch-Nyhan,Modifier,0,0,0,0,0,0,0,0,0,0
EDMD,Modifier,0,0,0,0,0,0,0,0,0,0
EDMD,Modifier,0,0,0,0,0,0,0,0,0,0
sporadic breast cancer,Modifier,0,0,1.12966,0,0,0,0,0,0,0
familial breast and ovarian cancer,Modifier,0,0,1.12966,0,0,0,0,0,1.07443,0
GM1-gangliosidosis,Modifier,0,0,0,0,0,0,0,0,0,0
FMF,Modifier,0,0,0,0,0,0,0,0,0,0
FMF,Modifier,0,0,0,0,0,0,0,0,0,0
myotonic dystrophy,Modifier,0,0,0,0,0,0,1.14098,0,0,0
cataract,Modifier,0,0,0,0,0,0,0,0,0,0
familial adenomatous polyposis,Modifier,0,0,0,0,0,0,0,0,0,0
adenomatous polyposis coli,Modifier,0,0,0,0,0,0,0,0,0,0
APC,Modifier,0,0,0,0,0,0,0,0,0,0
familial adenomatous polyposis,Modifier,0,0,0,0,0,0,0,0,0,0
FAP,Modifier,0,0,0,0,0,0,0,0,0,0
APC,Modifier,0,0,0,0,0,0,0,0,0,0
APC,Modifier,0,0,0,0,0,0,0,0,0,0
FAP,Modifier,0,0,0,0,0,0,0,0,0,0
APC,Modifier,0,0,0,0,0,0,0,0,0,0
FAP,Modifier,0,0,0,0,0,0,0,0,0,0
APC,Modifier,0,0,0,0,0,0,0,0,0,0
APC,Modifier,0,0,0,0,0,0,0,0,0,0
FAP,Modifier,0,0,0,0,0,0,0,0,0,0
Wiskott-Aldrich syndrome,Modifier,0,0,0,0,0,0,0,0,0,1.21605
WAS,Modifier,0,0,0,0,0,0,0,0,0,0
thrombocytopenic,Modifier,0,0,0,0,0,0,0,0,0,0
WAS,Modifier,0,0,0,0,0,0,0,0,0,0
WAS,Modifier,0,0,0,0,0,0,0,0,0,0
WAS,Modifier,0,0,0,0,0,0,0,0,0,0
tumour,Modifier,0,0,0,0,0,0,0,0,0,0
Wilms tumor,Modifier,0,0,0,0,0,0,0,0,0,0
neoplastic,Modifier,0,0,0,0,0,0,0,0,0,0
nonneoplastic,Modifier,0,0,0,0,0,0,0,0,0,0
DDS,Modifier,0,0,0,0,0,0,0,0,0,0
adrenoleukodystrophy,Modifier,0,0,0,0,0,0,1.14098,0,0,0
ALD,Modifier,0,0,0,0,0,0,0,0,0,0
ALD,Modifier,0,0,0,0,0,0,0,0,0,0
ALD,Modifier,0,0,0,0,0,0,0,0,0,0
ALD,Modifier,0,0,0,0,0,0,0,0,0,0
Glucose-6-phosphate dehydrogenase (G6PD; EC 1. 1. 1. 49) -deficient,Modifier,0,0,0,0,0,0,0,0,0,0
malaria,Modifier,0,0,0,0,0,0,0,0,0,0
thalassemia,Modifier,0,0,0,0,0,0,0,0,0,0
malarious,Modifier,0,0,0,0,0,0,0,0,0,0
tumor,Modifier,0,0,0,0,0,0,0,0,0,0
breast cancer,Modifier,0,0,1.12966,0,0,0,0,0,0,0
DMD,Modifier,0,0,0,0,0,0,0,0,0,0
Myotonic dystrophy,Modifier,0,0,0,0,0,0,1.14098,0,0,0
myotonic dystrophy,Modifier,0,0,0,0,0,0,1.14098,0,0,0
DM,Modifier,0,0,0,0,0,0,0,0,0,0
breast cancer,Modifier,0,0,1.12966,0,0,0,0,0,0,0
ALPS,Modifier,0,0,0,0,0,0,0,0,0,0
ALPS,Modifier,0,0,0,0,0,0,0,0,0,0
myotonic dystrophy,Modifier,0,0,0,0,0,0,1.14098,0,0,0
myotonic dystrophy,Modifier,0,0,0,0,0,0,1.14098,0,0,0
DM,Modifier,0,0,0,0,0,0,0,0,0,0
VWS,Modifier,0,0,0,0,0,0,0,0,0,0
VWS,Modifier,0,0,0,0,0,0,0,0,0,0
C7 deficiency,Modifier,0,0,0,1.37377,0,0,0,0,0,0
meningococcal,Modifier,0,0,0,0,0,0,0,0,0,0
complement deficient,Modifier,0,0,0,0,0,0,0,0,0,0
DMD,Modifier,0,0,0,0,0,0,0,0,0,0
BMD,Modifier,0,0,0,0,0,0,0,0,0,0
DMD,Modifier,0,0,0,0,0,0,0,0,0,0
retinoblastoma,Modifier,0,0,0,0,0,0,0,0,0,0
retinoblastoma,Modifier,0,0,0,0,0,0,0,0,0,0
retinoblastoma,Modifier,0,0,0,0,0,0,0,0,0,0
PDS,Modifier,0,0,0,0,0,0,0,0,0,0
PDS,Modifier,0,0,0,0,0,0,0,0,0,0
DFNB4,Modifier,0,0,0,0,0,0,0,0,0,0
PDS,Modifier,0,0,0,0,0,0,0,0,0,0
PDS,Modifier,0,0,0,0,0,0,0,0,0,0
PDS,Modifier,0,0,0,0,0,0,0,0,0,0
Pendred syndrome,Modifier,0,0,0,0,0,0,0,0,0,1.21605
PDS,Modifier,0,0,0,0,0,0,0,0,0,0
MLD,Modifier,0,0,0,0,0,0,0,0,0,0
XLRS,Modifier,0,0,0,0,0,0,0,0,0,0
alkaptonuria,Modifier,0,0,0,0,0,0,0,0,0,0
AKU,Modifier,0,0,0,0,0,0,0,0,0,0
AKU,Modifier,0,0,0,0,0,0,0,0,0,0
AKU,Modifier,0,0,0,0,0,0,0,0,0,0
AKU,Modifier,0,0,0,0,0,0,0,0,0,0
X-linked adrenoleukodystrophy,Modifier,0,0,0,0,0,0,1.14098,0,0,0
ALD,Modifier,0,0,0,0,0,0,0,0,0,0
LQT3,Modifier,0,0,0,0,0,0,0,0,0,0
aniridia,Modifier,0,0,0,0,0,0,0,0,0,0
PDS,Modifier,0,0,0,0,0,0,0,0,0,0
PDS,Modifier,0,0,0,0,0,0,0,0,0,0
PDS,Modifier,0,0,0,0,0,0,0,0,0,0
PDS,Modifier,0,0,0,0,0,0,0,0,0,0
tumor,Modifier,0,0,0,0,0,0,0,0,0,0
APC,Modifier,0,0,0,0,0,0,0,0,0,0
attenuated polyposis,Modifier,0,0,0,0,0,0,0,0,0,0
APC,Modifier,0,0,0,0,0,0,0,0,0,0
FAP,Modifier,0,0,0,0,0,0,0,0,0,0
APC,Modifier,0,0,0,0,0,0,0,0,0,0
FAP,Modifier,0,0,0,0,0,0,0,0,0,0
APC,Modifier,0,0,0,0,0,0,0,0,0,0
APC,Modifier,0,0,0,0,0,0,0,0,0,0
tumor,Modifier,0,0,0,0,0,0,0,0,0,0
Lesch-Nyhan,Modifier,0,0,0,0,0,0,0,0,0,0
HPRT deficient,Modifier,0,0,0,0,0,0,0,0,0,0
PKU,Modifier,0,0,0,0,0,0,0,0,0,0
HFE-deficient,Modifier,0,0,0,0,0,0,0,0,0,0
Wiskott-Aldrich syndrome,Modifier,0,0,0,0,0,0,0,0,0,1.21605
WAS,Modifier,0,0,0,0,0,0,0,0,0,0
WAS,Modifier,0,0,0,0,0,0,0,0,0,0
WAS,Modifier,0,0,0,0,0,0,0,0,0,0
WAS,Modifier,0,0,0,0,0,0,0,0,0,0
WAS,Modifier,0,0,0,0,0,0,0,0,0,0
WAS,Modifier,0,0,0,0,0,0,0,0,0,0
WAS,Modifier,0,0,0,0,0,0,0,0,0,0
ALD,Modifier,0,0,0,0,0,0,0,0,0,0
AMN,Modifier,0,0,0,0,0,0,0,0,0,0
Tay-Sachs disease,Modifier,0,0,0,0,1.22993,0,0,0,0,0
TSD,Modifier,0,0,0,0,0,0,0,0,0,0
TSD,Modifier,0,0,0,0,0,0,0,0,0,0
TSD,Modifier,0,0,0,0,0,0,0,0,0,0
Huntington disease,Modifier,0,0,0,0,1.22993,0,0,0,0,0
DM,Modifier,0,0,0,0,0,0,0,0,0,0
DM,Modifier,0,0,0,0,0,0,0,0,0,0
Li-Fraumeni syndrome,Modifier,0,0,0,0,0,0,0,0,0,1.21605
tumor,Modifier,0,0,0,0,0,0,0,0,0,0
tumor,Modifier,0,0,0,0,0,0,0,0,0,0
tumor,Modifier,0,0,0,0,0,0,0,0,0,0
PKU,Modifier,0,0,0,0,0,0,0,0,0,0
PKU,Modifier,0,0,0,0,0,0,0,0,0,0
APC,Modifier,0,0,0,0,0,0,0,0,0,0
APC,Modifier,0,0,0,0,0,0,0,0,0,0
FAP,Modifier,0,0,0,0,0,0,0,0,0,0
APC,Modifier,0,0,0,0,0,0,0,0,0,0
APC,Modifier,0,0,0,0,0,0,0,0,0,0
FAP,Modifier,0,0,0,0,0,0,0,0,0,0
DMD,Modifier,0,0,0,0,0,0,0,0,0,0
DMD,Modifier,0,0,0,0,0,0,0,0,0,0
DMD,Modifier,0,0,0,0,0,0,0,0,0,0
DMD,Modifier,0,0,0,0,0,0,0,0,0,0
DMD,Modifier,0,0,0,0,0,0,0,0,0,0
DMD,Modifier,0,0,0,0,0,0,0,0,0,0
glucose-6-phosphate dehydrogenase (G6PD) -deficient,Modifier,0,0,0,0,0,0,0,0,0,0
G6PD-deficient,Modifier,0,0,0,0,0,0,0,0,0,0
G6PD-deficient,Modifier,0,0,0,0,0,0,0,0,0,0
G6PD-deficient,Modifier,0,0,0,0,0,0,0,0,0,0
Norrie disease,Modifier,0,0,0,0,1.22993,0,0,0,0,0
NDP,Modifier,0,0,0,0,0,0,0,0,0,0
Norrie,Modifier,0,0,0,0,0,0,0,0,0,0
NDP,Modifier,0,0,0,0,0,0,0,0,0,0
NDP,Modifier,0,0,0,0,0,0,0,0,0,0
tumour,Modifier,0,0,0,0,0,0,0,0,0,0
DMD,Modifier,0,0,0,0,0,0,0,0,0,0
DMD,Modifier,0,0,0,0,0,0,0,0,0,0
DMD,Modifier,0,0,0,0,0,0,0,0,0,0
DMD,Modifier,0,0,0,0,0,0,0,0,0,0
APC,Modifier,0,0,0,0,0,0,0,0,0,0
cancer,Modifier,0,0,1.12966,0,0,0,0,0,0,0
APC,Modifier,0,0,0,0,0,0,0,0,0,0
APC,Modifier,0,0,0,0,0,0,0,0,0,0
galactosemia,Modifier,0,0,0,0,0,0,0,0,0,0
classic galactosemia,Modifier,0,0,0,0,0,0,0,0,0,0
galactosemia,Modifier,0,0,0,0,0,0,0,0,0,0
classic galactosemia,Modifier,0,0,0,0,0,0,0,0,0,0
DTD,Modifier,0,0,0,0,0,0,0,0,0,0
adrenoleukodystrophy,Modifier,0,0,0,0,0,0,1.14098,0,0,0
X-ALD,Modifier,0,0,0,0,0,0,0,0,0,0
fragile X syndrome,Modifier,0,0,0,0,0,0,0,0,0,1.21605
hemochromatosis,Modifier,0,0,0,0,0,0,0,0,0,0
hemochromatosis,Modifier,0,0,0,0,0,0,0,0,0,0
hemochromatosis,Modifier,0,0,0,0,0,0,0,0,0,0
hemochromatosis,Modifier,0,0,0,0,0,0,0,0,0,0
hemochromatosis,Modifier,0,0,0,0,0,0,0,0,0,0
hemochromatosis,Modifier,0,0,0,0,0,0,0,0,0,0
hemochromatosis,Modifier,0,0,0,0,0,0,0,0,0,0
malaria,Modifier,0,0,0,0,0,0,0,0,0,0
Tay-Sachs disease,Modifier,0,0,0,0,1.22993,0,0,0,0,0
TSD,Modifier,0,0,0,0,0,0,0,0,0,0
TSD,Modifier,0,0,0,0,0,0,0,0,0,0
TSD,Modifier,0,0,0,0,0,0,0,0,0,0
EDMD,Modifier,0,0,0,0,0,0,0,0,0,0
tumor,Modifier,0,0,0,0,0,0,0,0,0,0
melanoma,Modifier,0,0,0,0,0,0,0,0,0,0
tumor,Modifier,0,0,0,0,0,0,0,0,0,0
tumor,Modifier,0,0,0,0,0,0,0,0,0,0
alveolar rhabdomyosarcoma,Modifier,0,0,0,0,0,0,0,0,0,0
tumor,Modifier,0,0,0,0,0,0,0,0,0,0
attenuated APC,Modifier,0,0,0,0,0,0,0,0,0,0
APC,Modifier,0,0,0,0,0,0,0,0,0,0
APC,Modifier,0,0,0,0,0,0,0,0,0,0
APC,Modifier,0,0,0,0,0,0,0,0,0,0
AAPC,Modifier,0,0,0,0,0,0,0,0,0,0
APC,Modifier,0,0,0,0,0,0,0,0,0,0
APC,Modifier,0,0,0,0,0,0,0,0,0,0
APC,Modifier,0,0,0,0,0,0,0,0,0,0
attenuated polyposis,Modifier,0,0,0,0,0,0,0,0,0,0
AGU,Modifier,0,0,0,0,0,0,0,0,0,0
AGU,Modifier,0,0,0,0,0,0,0,0,0,0
hemochromatosis,Modifier,0,0,0,0,0,0,0,0,0,0
GH,Modifier,0,0,0,0,0,0,0,0,0,0
GH,Modifier,0,0,0,0,0,0,0,0,0,0
Lesch-Nyhan,Modifier,0,0,0,0,0,0,0,0,0,0
Lesch-Nyhan,Modifier,0,0,0,0,0,0,0,0,0,0
FMF,Modifier,0,0,0,0,0,0,0,0,0,0
FMF,Modifier,0,0,0,0,0,0,0,0,0,0
FMF,Modifier,0,0,0,0,0,0,0,0,0,0
Huntington disease,Modifier,0,0,0,0,1.22993,0,0,0,0,0
HD,Modifier,0,0,0,0,0,0,0,0,0,0
HD,Modifier,0,0,0,0,0,0,0,0,0,0
APC,Modifier,0,0,0,0,0,0,0,0,0,0
familial adenomatous polyposis,Modifier,0,0,0,0,0,0,0,0,0,0
adenomatous polyposis coli,Modifier,0,0,0,0,0,0,0,0,0,0
APC,Modifier,0,0,0,0,0,0,0,0,0,0
FAP,Modifier,0,0,0,0,0,0,0,0,0,0
APC,Modifier,0,0,0,0,0,0,0,0,0,0
FAP,Modifier,0,0,0,0,0,0,0,0,0,0
FAP,Modifier,0,0,0,0,0,0,0,0,0,0
FAP,Modifier,0,0,0,0,0,0,0,0,0,0
APC,Modifier,0,0,0,0,0,0,0,0,0,0
FAP,Modifier,0,0,0,0,0,0,0,0,0,0
APC,Modifier,0,0,0,0,0,0,0,0,0,0
DMD,Modifier,0,0,0,0,0,0,0,0,0,0
BMD,Modifier,0,0,0,0,0,0,0,0,0,0
DMD,Modifier,0,0,0,0,0,0,0,0,0,0
BMD,Modifier,0,0,0,0,0,0,0,0,0,0
muscle disease,Modifier,0,0,0,0,1.22993,0,0,0,0,0
galactosemia,Modifier,0,0,0,0,0,0,0,0,0,0
galactosemia,Modifier,0,0,0,0,0,0,0,0,0,0
galactosemia,Modifier,0,0,0,0,0,0,0,0,0,0
galactosemia,Modifier,0,0,0,0,0,0,0,0,0,0
PWS,Modifier,0,0,0,0,0,0,0,0,0,0
neurodevelopmentally handicapped,Modifier,0,0,0,0,0,0,0,0,0,0
PWS,Modifier,0,0,0,0,0,0,0,0,0,0
PWS,Modifier,0,0,0,0,0,0,0,0,0,0
neurodevelopmentally handicapped,Modifier,0,0,0,0,0,0,0,0,0,0
CTX,Modifier,0,0,0,0,0,0,0,0,0,0
CTX,Modifier,0,0,0,0,0,0,0,0,0,0
PLS,Modifier,0,0,0,0,0,0,0,0,0,0
periodontal disease,Modifier,0,0,0,0,1.22993,0,0,0,0,0
retinoblastoma,Modifier,0,0,0,0,0,0,0,0,0,0
retinoblastoma,Modifier,0,0,0,0,0,0,0,0,0,0
retinoblastoma,Modifier,0,0,0,0,0,0,0,0,0,0
retinoblastoma,Modifier,0,0,0,0,0,0,0,0,0,0
Wilms tumor,Modifier,0,0,0,0,0,0,0,0,0,0
Duchenne muscular dystrophy,Modifier,0,0,0,0,0,0,1.14098,1.09225,0,0
Duchenne muscular dystrophy,Modifier,0,0,0,0,0,0,1.14098,1.09225,0,0
DMD,Modifier,0,0,0,0,0,0,0,0,0,0
DMD,Modifier,0,0,0,0,0,0,0,0,0,0
TSD,Modifier,0,0,0,0,0,0,0,0,0,0
TSD,Modifier,0,0,0,0,0,0,0,0,0,0
TSD,Modifier,0,0,0,0,0,0,0,0,0,0
retinal degeneration,Modifier,0,0,0,0,0,0,0,0,0,0
retinal degeneration,Modifier,0,0,0,0,0,0,0,0,0,0
skin tumour,no Modifier,0,0,0,0,0,0,0,0,0,0
cancer,no Modifier,0,0,1.12966,0,0,0,0,0,0,0
colon cancers,no Modifier,0,0,1.12966,0,0,0,0,0,0,0
adenomatous polyposis coli,no Modifier,0,0,0,0,0,0,0,0,0,0
APC,no Modifier,0,0,0,0,0,0,0,0,0,0
colon and some other cancers,no Modifier,0,0,1.12966,0,0,0,0,0,0,0
skin tumours,no Modifier,0,0,0,0,0,0,0,0,0,0
pilomatricomas,no Modifier,0,0,0,0,0,0,0,0,0,0
pilomatricomas,no Modifier,0,0,0,0,0,0,0,0,0,0
skin tumour,no Modifier,0,0,0,0,0,0,0,0,0,0
pilomatricomas,no Modifier,0,0,0,0,0,0,0,0,0,0
tumours,no Modifier,0,0,0,0,0,0,0,0,0,0
tumours,no Modifier,0,0,0,0,0,0,0,0,0,0
hemochromatosis,no Modifier,0,0,0,0,0,0,0,0,0,0
Hereditary hemochromatosis,no Modifier,0,0,0,0,0,0,0,0,0,0
HH,no Modifier,0,0,0,0,0,0,0,0,0,0
autosomal recessive genetic disorder,no Modifier,0,0,0,0,0,0,0,0,0,0
HH,no Modifier,0,0,0,0,0,0,0,0,0,0
hemochromatosis,no Modifier,0,0,0,0,0,0,0,0,0,0
hemochromatosis,no Modifier,0,0,0,0,0,0,0,0,0,0
breast or ovarian cancer,no Modifier,0,0,1.12966,0,0,0,0,0,1.07443,0
cancer,no Modifier,0,0,1.12966,0,0,0,0,0,0,0
ovarian cancer,no Modifier,0,0,1.12966,0,0,0,0,0,1.07443,0
Familial deficiency of the seventh component of complement,no Modifier,0,0,0,1.37377,0,0,0,0,0,0
bacteremic infections due to Neisseria,no Modifier,0,0,0,0,0,0,0,0,0,0
disseminated gonococcal infection,no Modifier,0,0,0,0,0,0,0,0,0,0
meningococcal meningitis,no Modifier,0,0,0,0,0,0,0,0,0,0
arthritis,no Modifier,0,0,0,0,0,0,0,0,0,0
Complete absence of C7,no Modifier,0,0,0,0,0,0,0,0,0,0
meningococcal meningitis,no Modifier,0,0,0,0,0,0,0,0,0,0
arthritis,no Modifier,0,0,0,0,0,0,0,0,0,0
C7 deficiency,no Modifier,0,0,0,1.37377,0,0,0,0,0,0
C7 deficiency,no Modifier,0,0,0,1.37377,0,0,0,0,0,0
bacteremic neisseria infections,no Modifier,0,0,0,0,0,0,0,0,0,0
oromandibular dystonia,no Modifier,0,0,0,0,0,0,0,0,0,0
oromandibular dystonia,no Modifier,0,0,0,0,0,0,0,0,0,0
dystonia,no Modifier,0,0,0,0,0,0,0,0,0,0
dopa-responsive dystonia,no Modifier,0,0,0,0,0,0,0,0,0,0
familial Mediterranean fever,no Modifier,0,0,0,0,0,0,0,0,0,0
Familial Mediterranean fever,no Modifier,0,0,0,0,0,0,0,0,0,0
FMF,no Modifier,0,0,0,0,0,0,0,0,0,0
recessive disorder,no Modifier,0,0,0,0,0,0,0,0,0,0
serositis,no Modifier,0,0,0,0,0,0,0,0,0,0
synovitis,no Modifier,0,0,0,0,0,0,0,0,0,0
FMF,no Modifier,0,0,0,0,0,0,0,0,0,0
FMF,no Modifier,0,0,0,0,0,0,0,0,0,0
Autoimmune lymphoproliferative syndrome,no Modifier,0,0,0,0,0,0,0,0,0,1.21605
Autoimmune lymphoproliferative syndrome,no Modifier,0,0,0,0,0,0,0,0,0,1.21605
ALPS,no Modifier,0,0,0,0,0,0,0,0,0,0
disorder of lymphocyte homeostasis and immunological tolerance,no Modifier,0,0,0,0,0,0,0,0,0,0
ALPS,no Modifier,0,0,0,0,0,0,0,0,0,0
ALPS,no Modifier,0,0,0,0,0,0,0,0,0,0
X-linked adrenoleukodystrophy,no Modifier,0,0,0,0,0,0,1.14098,0,0,0
X-linked adrenoleukodystrophy,no Modifier,0,0,0,0,0,0,1.14098,0,0,0
ALD,no Modifier,0,0,0,0,0,0,0,0,0,0
inherited disease,no Modifier,0,0,0,0,1.22993,0,0,0,0,0
neurologic dysfunction,no Modifier,0,0,0,0,0,0,0,0,0,0
adrenal insufficiency,no Modifier,0,0,0,0,0,0,0,0,0,0
ALD,no Modifier,0,0,0,0,0,0,0,0,0,0
childhood cerebral ALD,no Modifier,0,0,0,0,0,0,0,0,0,0
neurologic deterioration,no Modifier,0,0,0,0,0,0,0,0,0,0
cerebral ALD,no Modifier,0,0,0,0,0,0,0,0,0,0
neurologic dysfunction,no Modifier,0,0,0,0,0,0,0,0,0,0
adrenomyeloneuropathy,no Modifier,0,0,0,0,0,0,0,0,0,0
Addison disease,no Modifier,0,0,0,0,1.22993,0,0,0,0,0
ALD,no Modifier,0,0,0,0,0,0,0,0,0,0
childhood cerebral ALD,no Modifier,0,0,0,0,0,0,0,0,0,0
cerebral ALD,no Modifier,0,0,0,0,0,0,0,0,0,0
adrenomyeloneuropathy,no Modifier,0,0,0,0,0,0,0,0,0,0
ALD,no Modifier,0,0,0,0,0,0,0,0,0,0
cerebral ALD,no Modifier,0,0,0,0,0,0,0,0,0,0
ALD,no Modifier,0,0,0,0,0,0,0,0,0,0
ALD,no Modifier,0,0,0,0,0,0,0,0,0,0
Absence of the seventh component of complement,no Modifier,0,0,0,0,0,0,0,0,0,0
chronic meningococcemia,no Modifier,0,0,0,0,0,0,0,0,0,0
vasculitis,no Modifier,0,0,0,0,0,0,0,0,0,0
fever,no Modifier,0,0,0,0,0,0,0,0,0,0
arthritis,no Modifier,0,0,0,0,0,0,0,0,0,0
cutaneous vasculitis,no Modifier,0,0,0,0,0,0,0,0,0,0
chronic meningococcemia,no Modifier,0,0,0,0,0,0,0,0,0,0
deficiency of the seventh component of complement,no Modifier,0,0,0,1.37377,0,0,0,0,0,0
deficiency of C7,no Modifier,0,0,0,1.37377,0,0,0,0,0,0
Chronic neisserial infection,no Modifier,0,0,0,0,0,0,0,0,0,0
C7 deficiency,no Modifier,0,0,0,1.37377,0,0,0,0,0,0
cutaneous vasculitis,no Modifier,0,0,0,0,0,0,0,0,0,0
dihydropyrimidine dehydrogenase deficiency,no Modifier,0,0,0,1.37377,0,0,0,0,0,0
Dihydropyrimidine dehydrogenase (DPD) deficiency,no Modifier,0,0,0,1.37377,0,0,0,0,0,0
autosomal recessive disease,no Modifier,0,0,0,0,1.22993,0,0,0,0,0
DPD deficiency,no Modifier,0,0,0,1.37377,0,0,0,0,0,0
deficiency of DPD,no Modifier,0,0,0,1.37377,0,0,0,0,0,0
convulsive disorders,no Modifier,0,0,0,0,0,0,0,0,0,0
motor retardation,no Modifier,0,0,0,0,0,0,0,0,0,0
mental retardation,no Modifier,0,0,0,0,0,0,0,0,0,0
clinical abnormalities,no Modifier,0,0,0,0,0,0,0,0,0,0
DPD deficiency,no Modifier,0,0,0,1.37377,0,0,0,0,0,0
glucose-6-phosphate dehydrogenase (G6PD) deficiency,no Modifier,0,0,0,1.37377,0,0,0,0,0,0
G6PD deficiency,no Modifier,0,0,0,1.37377,0,0,0,0,0,0
glucose-6-phosphate dehydrogenase (G6PD) deficiency,no Modifier,0,0,0,1.37377,0,0,0,0,0,0
G6PD deficiency,no Modifier,0,0,0,1.37377,0,0,0,0,0,0
G6PD deficiency,no Modifier,0,0,0,1.37377,0,0,0,0,0,0
Homozygous hypobetalipoproteinemia,no Modifier,0,0,0,0,0,0,0,0,0,0
abetalipoproproteinemia,no Modifier,0,0,0,0,0,0,0,0,0,0
homozygous hypobetalipoproteinemia,no Modifier,0,0,0,0,0,0,0,0,0,0
HBL,no Modifier,0,0,0,0,0,0,0,0,0,0
abetalipoproteinemia,no Modifier,0,0,0,0,0,0,0,0,0,0
Hereditary hemochromatosis,no Modifier,0,0,0,0,0,0,0,0,0,0
excess iron deposits,no Modifier,0,0,0,0,0,0,0,0,0,0
hemochromatosis,no Modifier,0,0,0,0,0,0,0,0,0,0
hepatic fibrosis,no Modifier,0,0,0,0,0,0,0,0,0,0
excessive alcohol consumption,no Modifier,0,0,0,0,0,0,0,0,0,0
cirrhosis,no Modifier,0,0,0,0,0,0,0,0,0,0
microvesicular steatosis,no Modifier,0,0,0,0,0,0,0,0,0,0
hereditary hemochromatosis,no Modifier,0,0,0,0,0,0,0,0,0,0
hepatomegaly,no Modifier,0,0,0,0,0,0,0,0,0,0
skin pigmentation,no Modifier,0,0,0,0,0,0,0,0,0,0
arthritis,no Modifier,0,0,0,0,0,0,0,0,0,0
hemochromatosis,no Modifier,0,0,0,0,0,0,0,0,0,0
Pelizaeus-Merzbacher disease,no Modifier,0,0,0,0,1.22993,0,0,0,0,0
Pelizaeus-Merzbacher disease,no Modifier,0,0,0,0,1.22993,0,0,0,0,0
"rare, sex-linked recessive, dysmyelinating disease of the central nervous system",no Modifier,0,0,0,0,1.22993,0,0,0,0,0
Pelizaeus-Merzbacher disease,no Modifier,0,0,0,0,1.22993,0,0,0,0,0
Pelizaeus-Merzbacher disease,no Modifier,0,0,0,0,1.22993,0,0,0,0,0
Pelizaeus-Merzbacher disease,no Modifier,0,0,0,0,1.22993,0,0,0,0,0
diastrophic dysplasia,no Modifier,0,0,0,0,0,0,0,0,0,0
chondrodysplasias,no Modifier,0,0,0,0,0,0,0,0,0,0
diastrophic dysplasia,no Modifier,0,0,0,0,0,0,0,0,0,0
platyspondyly,no Modifier,0,0,0,0,0,0,0,0,0,0
metatropic dysplasia,no Modifier,0,0,0,0,0,0,0,0,0,0
Pelizaeus-Merzbacher disease,no Modifier,0,0,0,0,1.22993,0,0,0,0,0
X-linked Pelizaeus-Merzbacher disease,no Modifier,0,0,0,0,1.22993,0,0,0,0,0
PMD,no Modifier,0,0,0,0,0,0,0,0,0,0
PMD,no Modifier,0,0,0,0,0,0,0,0,0,0
Gardner syndrome,no Modifier,0,0,0,0,0,0,0,0,0,1.21605
Gardner syndrome,no Modifier,0,0,0,0,0,0,0,0,0,1.21605
GS,no Modifier,0,0,0,0,0,0,0,0,0,0
mental retardation,no Modifier,0,0,0,0,0,0,0,0,0,0
craniofacial abnormalities,no Modifier,0,0,0,0,0,0,0,0,0,0
adenomatous polyposis coli,no Modifier,0,0,0,0,0,0,0,0,0,0
GS,no Modifier,0,0,0,0,0,0,0,0,0,0
familial polyposis coli,no Modifier,0,0,0,0,0,0,0,0,0,0
FPC,no Modifier,0,0,0,0,0,0,0,0,0,0
Type I human complement C2 deficiency,no Modifier,0,0,0,1.37377,0,0,0,0,0,0
deficiency of complement protein C2,no Modifier,0,0,0,1.37377,0,0,0,0,0,0
Type I C2 deficiency,no Modifier,0,0,0,1.37377,0,0,0,0,0,0
type I C2 deficiency,no Modifier,0,0,0,1.37377,0,0,0,0,0,0
type I human complement C2 deficiency,no Modifier,0,0,0,1.37377,0,0,0,0,0,0
type II C2 deficiency,no Modifier,0,0,0,1.37377,0,0,0,0,0,0
genetic defect,no Modifier,0,0,0,0,0,0,0,0,0,0
FMR1 deficiency,no Modifier,0,0,0,1.37377,0,0,0,0,0,0
Fragile X syndrome,no Modifier,0,0,0,0,0,0,0,0,0,1.21605
mental retardation,no Modifier,0,0,0,0,0,0,0,0,0,0
macroorchidism,no Modifier,0,0,0,0,0,0,0,0,0,0
fragile X syndrome,no Modifier,0,0,0,0,0,0,0,0,0,1.21605
fragile X syndrome,no Modifier,0,0,0,0,0,0,0,0,0,1.21605
Fabry disease,no Modifier,0,0,0,0,1.22993,0,0,0,0,0
Fabry disease,no Modifier,0,0,0,0,1.22993,0,0,0,0,0
FD,no Modifier,0,0,0,0,0,0,0,0,0,0
angiokeratoma corporis diffusum,no Modifier,0,0,0,0,0,0,0,0,0,0
X-linked inborn error of glycosphingolipid metabolism,no Modifier,0,0,0,0,0,0,0,0,0,0
angiokeratoma,no Modifier,0,0,0,0,0,0,0,0,0,0
severe acroparesthesia,no Modifier,0,0,0,0,0,0,0,0,0,0
renal failure,no Modifier,0,0,0,0,0,0,0,0,0,0
vasculopathy of the heart and brain,no Modifier,0,0,0,0,0,0,0,0,0,0
alpha-galactosidase deficiency,no Modifier,0,0,0,1.37377,0,0,0,0,0,0
alpha-Gal A deficiency,no Modifier,0,0,0,1.37377,0,0,0,0,0,0
FD,no Modifier,0,0,0,0,0,0,0,0,0,0
bipolar disorder,no Modifier,0,0,0,0,0,0,0,0,0,0
bipolar affective disorder,no Modifier,0,0,0,0,0,0,0,0,0,0
BPAD,no Modifier,0,0,0,0,0,0,0,0,0,0
BPAD,no Modifier,0,0,0,0,0,0,0,0,0,0
breast cancer,no Modifier,0,0,1.12966,0,0,0,0,0,0,0
breast and ovarian cancer,no Modifier,0,0,1.12966,0,0,0,0,0,1.07443,0
breast cancer,no Modifier,0,0,1.12966,0,0,0,0,0,0,0
breast cancer,no Modifier,0,0,1.12966,0,0,0,0,0,0,0
breast cancer,no Modifier,0,0,1.12966,0,0,0,0,0,0,0
breast cancer,no Modifier,0,0,1.12966,0,0,0,0,0,0,0
breast or ovarian cancer,no Modifier,0,0,1.12966,0,0,0,0,0,1.07443,0
breast cancer,no Modifier,0,0,1.12966,0,0,0,0,0,0,0
breast or ovarian cancer,no Modifier,0,0,1.12966,0,0,0,0,0,1.07443,0
choroideremia,no Modifier,0,0,0,0,0,0,0,0,0,0
Choroideremia,no Modifier,0,0,0,0,0,0,0,0,0,0
CHM,no Modifier,0,0,0,0,0,0,0,0,0,0
X-linked progressive degeneration of the choroid and retina,no Modifier,0,0,0,0,0,0,0,0,0,0
X-linked adrenoleukodystrophy,no Modifier,0,0,0,0,0,0,1.14098,0,0,0
ALD,no Modifier,0,0,0,0,0,0,0,0,0,0
adolescent ALD,no Modifier,0,0,0,0,0,0,0,0,0,0
cerebral ALD,no Modifier,0,0,0,0,0,0,0,0,0,0
adrenomyeloneuropathy,no Modifier,0,0,0,0,0,0,0,0,0,0
Addison only,no Modifier,0,0,0,0,0,0,0,0,0,0
Duchenne muscular dystrophy,no Modifier,0,0,0,0,0,0,1.14098,1.09225,0,0
DMD,no Modifier,0,0,0,0,0,0,0,0,0,0
DMD,no Modifier,0,0,0,0,0,0,0,0,0,0
muscular injury,no Modifier,0,0,0,0,0,0,0,1.09225,0,0
muscular dystrophy,no Modifier,0,0,0,0,0,0,1.14098,1.09225,0,0
DMD,no Modifier,0,0,0,0,0,0,0,0,0,0
metabolic disorder,no Modifier,0,0,0,0,0,0,0,0,0,0
normotriglyceridemic abetalipoproteinemia,no Modifier,0,0,0,0,0,0,0,0,0,0
normotriglyceridemic abetalipoproteinemia,no Modifier,0,0,0,0,0,0,0,0,0,0
homozygous hypobetalipoproteinemia,no Modifier,0,0,0,0,0,0,0,0,0,0
von Willebrand disease type B,no Modifier,0,0,0,0,1.22993,0,0,0,0,0
von Willebrand disease type B,no Modifier,0,0,0,0,1.22993,0,0,0,0,0
von Willebrand disease type B,no Modifier,0,0,0,0,1.22993,0,0,0,0,0
von Willebrand disease type B,no Modifier,0,0,0,0,1.22993,0,0,0,0,0
male breast cancer,no Modifier,0,0,1.12966,0,0,0,0,0,0,0
breast-ovarian syndrome,no Modifier,0,0,0,0,0,0,0,0,1.07443,1.21605
autosomal recessive disease glucose/galactose malabsorption,no Modifier,0,0,0,0,1.22993,0,0,0,0,0
genetic diseases,no Modifier,0,0,0,0,1.22993,0,0,0,0,0
Deficiency of beta-hexosaminidase A,no Modifier,0,0,0,0,0,0,0,0,0,0
Tay-Sachs disease,no Modifier,0,0,0,0,1.22993,0,0,0,0,0
deficient in Hex A,no Modifier,0,0,0,0,0,0,0,0,0,0
Tay-Sachs disease,no Modifier,0,0,0,0,1.22993,0,0,0,0,0
TSD,no Modifier,0,0,0,0,0,0,0,0,0,0
Canavan disease,no Modifier,0,0,0,0,1.22993,0,0,0,0,0
Canavan disease,no Modifier,0,0,0,0,1.22993,0,0,0,0,0
spongy degeneration of the brain,no Modifier,0,0,0,0,0,0,0,0,0,0
leukodystrophy,no Modifier,0,0,0,0,0,0,1.14098,0,0,0
deficiency of aspartoacylase,no Modifier,0,0,0,1.37377,0,0,0,0,0,0
Canavan disease,no Modifier,0,0,0,0,1.22993,0,0,0,0,0
trinucleotide repeat disorders,no Modifier,0,0,0,0,0,0,0,0,0,0
Machado-Joseph disease,no Modifier,0,0,0,0,1.22993,0,0,0,0,0
MJD,no Modifier,0,0,0,0,0,0,0,0,0,0
Duchenne muscular dystrophy,no Modifier,0,0,0,0,0,0,1.14098,1.09225,0,0
DMD,no Modifier,0,0,0,0,0,0,0,0,0,0
alkaptonuria,no Modifier,0,0,0,0,0,0,0,0,0,0
AKU,no Modifier,0,0,0,0,0,0,0,0,0,0
Alkaptonuria,no Modifier,0,0,0,0,0,0,0,0,0,0
AKU,no Modifier,0,0,0,0,0,0,0,0,0,0
autosomal recessive disorder,no Modifier,0,0,0,0,0,0,0,0,0,0
Ochronosis,no Modifier,0,0,0,0,0,0,0,0,0,0
ochronotic arthropathy,no Modifier,0,0,0,0,0,0,0,0,0,0
alkaptonuria,no Modifier,0,0,0,0,0,0,0,0,0,0
Deficiency of the ninth component of human complement,no Modifier,0,0,0,0,0,0,0,0,0,0
complement deficiency,no Modifier,0,0,0,1.37377,0,0,0,0,0,0
C9 deficiency,no Modifier,0,0,0,1.37377,0,0,0,0,0,0
C9 deficiency,no Modifier,0,0,0,1.37377,0,0,0,0,0,0
C9 deficiency,no Modifier,0,0,0,1.37377,0,0,0,0,0,0
Lesch-Nyhan syndrome,no Modifier,0,0,0,0,0,0,0,0,0,1.21605
hypoxanthine phosphoribosyltransferase [HPRT] deficiency,no Modifier,0,0,0,1.37377,0,0,0,0,0,0
X-linked Emery-Dreifuss muscular dystrophy,no Modifier,0,0,0,0,0,0,1.14098,1.09225,0,0
Emery-Dreifuss muscular dystrophy,no Modifier,0,0,0,0,0,0,1.14098,1.09225,0,0
EDMD,no Modifier,0,0,0,0,0,0,0,0,0,0
X-linked recessive muscular dystrophy,no Modifier,0,0,0,0,0,0,1.14098,1.09225,0,0
"contractures of the elbows, Achilles tendons and spine",no Modifier,0,0,0,0,0,0,0,0,0,0
muscle wasting,no Modifier,0,0,0,0,0,0,0,0,0,0
weakness,no Modifier,0,0,0,0,0,0,0,0,0,0
cardiomyopathy,no Modifier,0,0,0,0,0,0,0,0,0,0
cardiac conduction defects,no Modifier,0,0,0,0,0,0,0,0,0,0
EDMD,no Modifier,0,0,0,0,0,0,0,0,0,0
elbow contractures,no Modifier,0,0,0,0,0,0,0,0,0,0
ankle contractures,no Modifier,0,0,0,0,0,0,0,0,0,0
upper limb weakness,no Modifier,0,0,0,0,0,0,0,0,0,0
lower limb weakness,no Modifier,0,0,0,0,0,0,0,0,0,0
cardiac involvement,no Modifier,0,0,0,0,0,0,0,0,0,0
EDMD,no Modifier,0,0,0,0,0,0,0,0,0,0
non-hereditary (sporadic) breast cancer,no Modifier,0,0,1.12966,0,0,0,0,0,0,0
carcinoma in situ,no Modifier,0,0,0,0,0,0,0,0,0,0
invasive cancer,no Modifier,0,0,1.12966,0,0,0,0,0,0,0
breast cancer,no Modifier,0,0,1.12966,0,0,0,0,0,0,0
Pelizaeus-Merzbacher disease,no Modifier,0,0,0,0,1.22993,0,0,0,0,0
Pelizaeus-Merzbacher disease,no Modifier,0,0,0,0,1.22993,0,0,0,0,0
PMD,no Modifier,0,0,0,0,0,0,0,0,0,0
PMD,no Modifier,0,0,0,0,0,0,0,0,0,0
PMD,no Modifier,0,0,0,0,0,0,0,0,0,0
genetic disorders,no Modifier,0,0,0,0,0,0,0,0,0,0
myotonic dystrophy,no Modifier,0,0,0,0,0,0,1.14098,0,0,0
myotonic dystrophy,no Modifier,0,0,0,0,0,0,1.14098,0,0,0
DM,no Modifier,0,0,0,0,0,0,0,0,0,0
cardiac involvement,no Modifier,0,0,0,0,0,0,0,0,0,0
GM1-gangliosidosis,no Modifier,0,0,0,0,0,0,0,0,0,0
lysosomal storage disorder,no Modifier,0,0,0,0,0,0,0,0,0,0
deficiency of acid beta-galactosidase,no Modifier,0,0,0,1.37377,0,0,0,0,0,0
cardiac involvement,no Modifier,0,0,0,0,0,0,0,0,0,0
GM1-gangliosidosis,no Modifier,0,0,0,0,0,0,0,0,0,0
cardiac involvement,no Modifier,0,0,0,0,0,0,0,0,0,0
cardiac abnormalities,no Modifier,0,0,0,0,0,0,0,0,0,0
genetic lesions,no Modifier,0,0,0,0,0,0,0,0,0,0
cardiomyopathy,no Modifier,0,0,0,0,0,0,0,0,0,0
familial Mediterranean fever,no Modifier,0,0,0,0,0,0,0,0,0,0
familial Mediterranean fever,no Modifier,0,0,0,0,0,0,0,0,0,0
FMF,no Modifier,0,0,0,0,0,0,0,0,0,0
FMF,no Modifier,0,0,0,0,0,0,0,0,0,0
deficient in Six5,no Modifier,0,0,0,0,0,0,0,0,0,0
cataracts,no Modifier,0,0,0,0,0,0,0,0,0,0
myotonic dystrophy,no Modifier,0,0,0,0,0,0,1.14098,0,0,0
myotonic dystrophy,no Modifier,0,0,0,0,0,0,1.14098,0,0,0
dominantly inherited disease,no Modifier,0,0,0,0,1.22993,0,0,0,0,0
muscle dystrophy,no Modifier,0,0,0,0,0,0,1.14098,0,0,0
myotonia,no Modifier,0,0,0,0,0,0,0,0,0,0
cataracts,no Modifier,0,0,0,0,0,0,0,0,0,0
cardiac conduction defects,no Modifier,0,0,0,0,0,0,0,0,0,0
myopathy,no Modifier,0,0,0,0,0,0,0,0,0,0
cardiac conduction abnormalities,no Modifier,0,0,0,0,0,0,0,0,0,0
myotonic dystrophy,no Modifier,0,0,0,0,0,0,1.14098,0,0,0
myotonia,no Modifier,0,0,0,0,0,0,0,0,0,0
cataracts,no Modifier,0,0,0,0,0,0,0,0,0,0
SIX5 deficiency,no Modifier,0,0,0,1.37377,0,0,0,0,0,0
abnormalities of skeletal muscle function,no Modifier,0,0,0,0,0,0,0,0,0,0
lenticular opacities,no Modifier,0,0,0,0,0,0,0,0,0,0
SIX5 deficiency,no Modifier,0,0,0,1.37377,0,0,0,0,0,0
myotonic dystrophy,no Modifier,0,0,0,0,0,0,1.14098,0,0,0
myotonic dystrophy,no Modifier,0,0,0,0,0,0,1.14098,0,0,0
multigenic disorder,no Modifier,0,0,0,0,0,0,0,0,0,0
deficiency of C5,no Modifier,0,0,0,1.37377,0,0,0,0,0,0
discoid lupus erythematosus,no Modifier,0,0,0,0,0,0,0,0,0,0
discoid lupus erythematosus,no Modifier,0,0,0,0,0,0,0,0,0,0
Hypocomplementemia,no Modifier,0,0,0,0,0,0,0,0,0,0
deficiency of C5,no Modifier,0,0,0,1.37377,0,0,0,0,0,0
discoid lupus erythematosus,no Modifier,0,0,0,0,0,0,0,0,0,0
C5 deficiency,no Modifier,0,0,0,1.37377,0,0,0,0,0,0
WAS,no Modifier,0,0,0,0,0,0,0,0,0,0
Wiskott-Aldrich syndrome,no Modifier,0,0,0,0,0,0,0,0,0,1.21605
WAS,no Modifier,0,0,0,0,0,0,0,0,0,0
WAS,no Modifier,0,0,0,0,0,0,0,0,0,0
thrombocytopenia,no Modifier,0,0,0,0,0,0,0,0,0,0
WAS,no Modifier,0,0,0,0,0,0,0,0,0,0
inherited breast and ovarian cancers,no Modifier,0,0,1.12966,0,0,0,0,0,1.07443,0
breast cancer,no Modifier,0,0,1.12966,0,0,0,0,0,0,0
Spinocerebellar ataxia type-3,no Modifier,0,0,0,0,0,0,0,0,0,0
Machado-Joseph disease,no Modifier,0,0,0,0,1.22993,0,0,0,0,0
SCA3,no Modifier,0,0,0,0,0,0,0,0,0,0
MJD,no Modifier,0,0,0,0,0,0,0,0,0,0
CAG/polyglutamine repeat disease,no Modifier,0,0,0,0,1.22993,0,0,0,0,0
polyglutamine disease,no Modifier,0,0,0,0,1.22993,0,0,0,0,0
neuronal dysfunction,no Modifier,0,0,0,0,0,0,0,0,0,0
SCA3,no Modifier,0,0,0,0,0,0,0,0,0,0
MJD,no Modifier,0,0,0,0,0,0,0,0,0,0
SCA3,no Modifier,0,0,0,0,0,0,0,0,0,0
MJD,no Modifier,0,0,0,0,0,0,0,0,0,0
urogenital abnormalities,no Modifier,0,0,0,0,0,0,0,0,0,0
Denys-Drash syndrome,no Modifier,0,0,0,0,0,0,0,0,0,1.21605
WT1 dysfunction,no Modifier,0,0,0,0,0,0,0,0,0,0
Wilms tumor,no Modifier,0,0,0,0,0,0,0,0,0,0
mesothelioma,no Modifier,0,0,0,0,0,0,0,0,0,0
leukemias,no Modifier,0,0,0,0,0,0,0,0,0,0
breast cancer,no Modifier,0,0,1.12966,0,0,0,0,0,0,0
glomerulosclerosis,no Modifier,0,0,0,0,0,0,0,0,0,0
Denys-Drash syndrome,no Modifier,0,0,0,0,0,0,0,0,0,1.21605
DDS,no Modifier,0,0,0,0,0,0,0,0,0,0
DDS,no Modifier,0,0,0,0,0,0,0,0,0,0
nephropathy,no Modifier,0,0,0,0,0,0,0,0,0,0
mesangial sclerosis,no Modifier,0,0,0,0,0,0,0,0,0,0
pseudohermaphroditism,no Modifier,0,0,0,0,0,0,0,0,0,0
Wilms tumor,no Modifier,0,0,0,0,0,0,0,0,0,0
WT,no Modifier,0,0,0,0,0,0,0,0,0,0
mesangial sclerosis,no Modifier,0,0,0,0,0,0,0,0,0,0
DDS,no Modifier,0,0,0,0,0,0,0,0,0,0
Male genital defects,no Modifier,0,0,0,0,0,0,0,0,0,0
Wilms tumor,no Modifier,0,0,0,0,0,0,0,0,0,0
Wt1 dysfunction,no Modifier,0,0,0,0,0,0,0,0,0,0
Wilms tumorigenesis,no Modifier,0,0,0,0,0,0,0,0,0,0
WT,no Modifier,0,0,0,0,0,0,0,0,0,0
X-linked Emery-Dreifuss muscular dystrophy,no Modifier,0,0,0,0,0,0,1.14098,1.09225,0,0
contractures of the Achilles tendons,no Modifier,0,0,0,0,0,0,0,0,0,0
contractures of the elbows,no Modifier,0,0,0,0,0,0,0,0,0,0
cardiac abnormality,no Modifier,0,0,0,0,0,0,0,0,0,0
X-linked Emery-Dreifuss muscular dystrophy,no Modifier,0,0,0,0,0,0,1.14098,1.09225,0,0
EDMD,no Modifier,0,0,0,0,0,0,0,0,0,0
EDMD,no Modifier,0,0,0,0,0,0,0,0,0,0
sudden cardiac death,no Modifier,0,0,0,0,0,0,0,0,0,0
Adrenoleukodystrophy,no Modifier,0,0,0,0,0,0,1.14098,0,0,0
Glucose-6-phosphate dehydrogenase deficiency,no Modifier,0,0,0,1.37377,0,0,0,0,0,0
G6PD deficiency,no Modifier,0,0,0,1.37377,0,0,0,0,0,0
G6PD deficiency,no Modifier,0,0,0,1.37377,0,0,0,0,0,0
G6PD deficiency,no Modifier,0,0,0,1.37377,0,0,0,0,0,0
malaria,no Modifier,0,0,0,0,0,0,0,0,0,0
fatal hemolysis,no Modifier,0,0,0,0,0,0,0,0,0,0
C3 deficiency,no Modifier,0,0,0,1.37377,0,0,0,0,0,0
glomerulonephritis,no Modifier,0,0,0,0,0,0,0,0,0,0
deficiency of the third component of complement,no Modifier,0,0,0,1.37377,0,0,0,0,0,0
bacterial infections,no Modifier,0,0,0,0,0,0,0,0,0,0
pneumonia,no Modifier,0,0,0,0,0,0,0,0,0,0
mesangiopathic glomerulonephritis,no Modifier,0,0,0,0,0,0,0,0,0,0
C3 deficiency,no Modifier,0,0,0,1.37377,0,0,0,0,0,0
immune-complex disease,no Modifier,0,0,0,0,1.22993,0,0,0,0,0
pyogenic infections,no Modifier,0,0,0,0,0,0,0,0,0,0
C3 deficiency,no Modifier,0,0,0,1.37377,0,0,0,0,0,0
Lesch-Nyhan syndrome,no Modifier,0,0,0,0,0,0,0,0,0,1.21605
HPRT enzyme deficiency,no Modifier,0,0,0,1.37377,0,0,0,0,0,0
Lesch-Nyhan syndrome,no Modifier,0,0,0,0,0,0,0,0,0,1.21605
familial breast and ovarian cancers,no Modifier,0,0,1.12966,0,0,0,0,0,1.07443,0
Duchenne muscular dystrophy,no Modifier,0,0,0,0,0,0,1.14098,1.09225,0,0
Duchenne muscular dystrophy,no Modifier,0,0,0,0,0,0,1.14098,1.09225,0,0
DMD,no Modifier,0,0,0,0,0,0,0,0,0,0
DMD,no Modifier,0,0,0,0,0,0,0,0,0,0
myotonic dystrophy,no Modifier,0,0,0,0,0,0,1.14098,0,0,0
DM,no Modifier,0,0,0,0,0,0,0,0,0,0
DM,no Modifier,0,0,0,0,0,0,0,0,0,0
DM,no Modifier,0,0,0,0,0,0,0,0,0,0
enzyme deficiency,no Modifier,0,0,0,1.37377,0,0,0,0,0,0
haemolysis,no Modifier,0,0,0,0,0,0,0,0,0,0
G6PD deficiency,no Modifier,0,0,0,1.37377,0,0,0,0,0,0
autosomal recessive disorder,no Modifier,0,0,0,0,0,0,0,0,0,0
ataxia-telangiectasia,no Modifier,0,0,0,0,0,0,0,0,0,0
A-T,no Modifier,0,0,0,0,0,0,0,0,0,0
breast cancer,no Modifier,0,0,1.12966,0,0,0,0,0,0,0
breast cancer,no Modifier,0,0,1.12966,0,0,0,0,0,0,0
sporadic breast cancer,no Modifier,0,0,1.12966,0,0,0,0,0,0,0
breast cancer,no Modifier,0,0,1.12966,0,0,0,0,0,0,0
Autoimmune lymphoproliferative syndrome,no Modifier,0,0,0,0,0,0,0,0,0,1.21605
ALPS,no Modifier,0,0,0,0,0,0,0,0,0,0
Autoimmune lymphoproliferative syndrome,no Modifier,0,0,0,0,0,0,0,0,0,1.21605
ALPS,no Modifier,0,0,0,0,0,0,0,0,0,0
ALPS,no Modifier,0,0,0,0,0,0,0,0,0,0
galactosemia,no Modifier,0,0,0,0,0,0,0,0,0,0
galactosemia,no Modifier,0,0,0,0,0,0,0,0,0,0
classic galactosemia,no Modifier,0,0,0,0,0,0,0,0,0,0
galactosemia,no Modifier,0,0,0,0,0,0,0,0,0,0
galactosemia,no Modifier,0,0,0,0,0,0,0,0,0,0
galactosemia,no Modifier,0,0,0,0,0,0,0,0,0,0
galactosemia,no Modifier,0,0,0,0,0,0,0,0,0,0
Myotonic dystrophy,no Modifier,0,0,0,0,0,0,1.14098,0,0,0
DM,no Modifier,0,0,0,0,0,0,0,0,0,0
inherited neuromuscular disease,no Modifier,0,0,0,0,1.22993,0,0,1.09225,0,0
genetic defect,no Modifier,0,0,0,0,0,0,0,0,0,0
van der Woude syndrome,no Modifier,0,0,0,0,0,0,0,0,0,1.21605
cleft palate,no Modifier,0,0,0,0,0,0,0,0,0,0
van der Woude syndrome,no Modifier,0,0,0,0,0,0,0,0,0,1.21605
VWS,no Modifier,0,0,0,0,0,0,0,0,0,0
pits and/or sinuses of the lower lip,no Modifier,0,0,0,0,0,0,0,0,0,0
cleft lip/palate,no Modifier,0,0,0,0,0,0,0,0,0,0
CL/P,no Modifier,0,0,0,0,0,0,0,0,0,0
cleft palate,no Modifier,0,0,0,0,0,0,0,0,0,0
CP,no Modifier,0,0,0,0,0,0,0,0,0,0
bifid uvula,no Modifier,0,0,0,0,0,0,0,0,0,0
hypodontia,no Modifier,0,0,0,0,0,0,0,0,0,0
H,no Modifier,0,0,0,0,0,0,0,0,0,0
VWS,no Modifier,0,0,0,0,0,0,0,0,0,0
CL/P,no Modifier,0,0,0,0,0,0,0,0,0,0
CP,no Modifier,0,0,0,0,0,0,0,0,0,0
CP,no Modifier,0,0,0,0,0,0,0,0,0,0
VWS,no Modifier,0,0,0,0,0,0,0,0,0,0
clefts,no Modifier,0,0,0,0,0,0,0,0,0,0
VWS,no Modifier,0,0,0,0,0,0,0,0,0,0
CP,no Modifier,0,0,0,0,0,0,0,0,0,0
VWS,no Modifier,0,0,0,0,0,0,0,0,0,0
CP,no Modifier,0,0,0,0,0,0,0,0,0,0
enzyme deficiency,no Modifier,0,0,0,1.37377,0,0,0,0,0,0
hemolytic anemia,no Modifier,0,0,0,0,0,0,0,0,0,0
Glucose-6-phosphate dehydrogenase (G6PD; EC 1. 1. 1. 49) deficiency,no Modifier,0,0,0,1.37377,0,0,0,0,0,0
genetic abnormality,no Modifier,0,0,0,0,0,0,0,0,0,0
enzyme deficiency,no Modifier,0,0,0,1.37377,0,0,0,0,0,0
favism,no Modifier,0,0,0,0,0,0,0,0,0,0
neonatal jaundice,no Modifier,0,0,0,0,0,0,0,0,0,0
hemolytic anemia,no Modifier,0,0,0,0,0,0,0,0,0,0
G6PD deficiency,no Modifier,0,0,0,1.37377,0,0,0,0,0,0
CETP deficiency,no Modifier,0,0,0,1.37377,0,0,0,0,0,0
CETP deficiency,no Modifier,0,0,0,1.37377,0,0,0,0,0,0
hypercholesterolemia,no Modifier,0,0,0,0,0,0,0,0,0,0
CETP deficiency,no Modifier,0,0,0,1.37377,0,0,0,0,0,0
CETP deficiency,no Modifier,0,0,0,1.37377,0,0,0,0,0,0
premature atherosclerosis,no Modifier,0,0,0,0,0,0,0,0,0,0
CETP deficiency,no Modifier,0,0,0,1.37377,0,0,0,0,0,0
CETP deficiency,no Modifier,0,0,0,1.37377,0,0,0,0,0,0
deficiency of the seventh component of complement,no Modifier,0,0,0,1.37377,0,0,0,0,0,0
meningococcal infection,no Modifier,0,0,0,0,0,0,0,0,0,0
Terminal complement component deficiency,no Modifier,0,0,0,1.37377,0,0,0,0,0,0
meningococcal infection,no Modifier,0,0,0,0,0,0,0,0,0,0
meningococcal infection,no Modifier,0,0,0,0,0,0,0,0,0,0
terminal complement deficiency,no Modifier,0,0,0,1.37377,0,0,0,0,0,0
completely deficient in the seventh component of complement,no Modifier,0,0,0,0,0,0,0,0,0,0
C7 deficient,no Modifier,0,0,0,0,0,0,0,0,0,0
meningococcal infection,no Modifier,0,0,0,0,0,0,0,0,0,0
muscular dystrophy,no Modifier,0,0,0,0,0,0,1.14098,1.09225,0,0
Duchenne or Becker muscular dystrophy,no Modifier,0,0,0,0,0,0,1.14098,1.09225,0,0
DMD,no Modifier,0,0,0,0,0,0,0,0,0,0
BMD,no Modifier,0,0,0,0,0,0,0,0,0,0
DMD,no Modifier,0,0,0,0,0,0,0,0,0,0
hereditary retinoblastoma,no Modifier,0,0,0,0,0,0,0,0,0,0
hereditary retinoblastoma,no Modifier,0,0,0,0,0,0,0,0,0,0
Pendred syndrome,no Modifier,0,0,0,0,0,0,0,0,0,1.21605
non-syndromic hearing loss,no Modifier,0,0,0,0,0,0,0,0,0,0
DFNB4,no Modifier,0,0,0,0,0,0,0,0,0,0
Pendred syndrome,no Modifier,0,0,0,0,0,0,0,0,0,1.21605
autosomal recessive non-syndromic hearing loss,no Modifier,0,0,0,0,0,0,0,0,0,0
non-syndromic hearing loss,no Modifier,0,0,0,0,0,0,0,0,0,0
Pendred syndrome,no Modifier,0,0,0,0,0,0,0,0,0,1.21605
non-syndromic hearing loss,no Modifier,0,0,0,0,0,0,0,0,0,0
non-syndromic hearing loss,no Modifier,0,0,0,0,0,0,0,0,0,0
Pendred syndrome,no Modifier,0,0,0,0,0,0,0,0,0,1.21605
DFNB4,no Modifier,0,0,0,0,0,0,0,0,0,0
goiter,no Modifier,0,0,0,0,0,0,0,0,0,0
DFNB4,no Modifier,0,0,0,0,0,0,0,0,0,0
metachromatic leukodystrophy,no Modifier,0,0,0,0,0,0,1.14098,0,0,0
metachromatic leukodystrophy,no Modifier,0,0,0,0,0,0,1.14098,0,0,0
MLD,no Modifier,0,0,0,0,0,0,0,0,0,0
MLD,no Modifier,0,0,0,0,0,0,0,0,0,0
MLD,no Modifier,0,0,0,0,0,0,0,0,0,0
Classical galactosemia,no Modifier,0,0,0,0,0,0,0,0,0,0
Classical galactosemia,no Modifier,0,0,0,0,0,0,0,0,0,0
galactosemia,no Modifier,0,0,0,0,0,0,0,0,0,0
X-linked retinoschisis,no Modifier,0,0,0,0,0,0,0,0,0,0
X-linked retinoschisis,no Modifier,0,0,0,0,0,0,0,0,0,0
XLRS,no Modifier,0,0,0,0,0,0,0,0,0,0
vitreoretinal dystrophy,no Modifier,0,0,0,0,0,0,1.14098,0,0,0
visual loss,no Modifier,0,0,0,0,0,0,0,0,0,0
XLRS,no Modifier,0,0,0,0,0,0,0,0,0,0
genetic abnormalities,no Modifier,0,0,0,0,0,0,0,0,0,0
XLRS,no Modifier,0,0,0,0,0,0,0,0,0,0
XLRS,no Modifier,0,0,0,0,0,0,0,0,0,0
hypomyelination,no Modifier,0,0,0,0,0,0,0,0,0,0
glial cell death,no Modifier,0,0,0,0,0,0,0,0,0,0
genetic disorders,no Modifier,0,0,0,0,0,0,0,0,0,0
Pelizaeus-Merzbacher disease,no Modifier,0,0,0,0,1.22993,0,0,0,0,0
degeneration and premature cell death of oligodendrocytes,no Modifier,0,0,0,0,0,0,0,0,0,0
hypomyelination,no Modifier,0,0,0,0,0,0,0,0,0,0
myelin-deficient,no Modifier,0,0,0,0,0,0,0,0,0,0
Hypomyelination,no Modifier,0,0,0,0,0,0,0,0,0,0
oligodendrocyte degeneration,no Modifier,0,0,0,0,0,0,0,0,0,0
Pelizaeus-Merzbacher disease,no Modifier,0,0,0,0,1.22993,0,0,0,0,0
Alkaptonuria,no Modifier,0,0,0,0,0,0,0,0,0,0
AKU,no Modifier,0,0,0,0,0,0,0,0,0,0
inborn error of metabolism,no Modifier,0,0,0,0,0,0,0,0,0,0
Adrenoleukodystrophy,no Modifier,0,0,0,0,0,0,1.14098,0,0,0
ALD,no Modifier,0,0,0,0,0,0,0,0,0,0
X-linked disease,no Modifier,0,0,0,0,1.22993,0,0,0,0,0
cerebral ALD,no Modifier,0,0,0,0,0,0,0,0,0,0
adrenomyeloneuropathy,no Modifier,0,0,0,0,0,0,0,0,0,0
AMN,no Modifier,0,0,0,0,0,0,0,0,0,0
ALD,no Modifier,0,0,0,0,0,0,0,0,0,0
Central nervous system demyelination,no Modifier,0,0,0,0,0,0,0,0,0,0
AMN,no Modifier,0,0,0,0,0,0,0,0,0,0
Adrenal insufficiency,no Modifier,0,0,0,0,0,0,0,0,0,0
Addisons disease,no Modifier,0,0,0,0,1.22993,0,0,0,0,0
ALD,no Modifier,0,0,0,0,0,0,0,0,0,0
ALD,no Modifier,0,0,0,0,0,0,0,0,0,0
ALD,no Modifier,0,0,0,0,0,0,0,0,0,0
ALD,no Modifier,0,0,0,0,0,0,0,0,0,0
Brugada syndrome,no Modifier,0,0,0,0,0,0,0,0,0,1.21605
congenital long-QT syndrome,no Modifier,0,0,0,0,0,0,0,0,0,1.21605
LQT3,no Modifier,0,0,0,0,0,0,0,0,0,0
idiopathic ventricular fibrillation,no Modifier,0,0,0,0,0,0,0,0,0,0
IVF,no Modifier,0,0,0,0,0,0,0,0,0,0
IVF,no Modifier,0,0,0,0,0,0,0,0,0,0
IVF,no Modifier,0,0,0,0,0,0,0,0,0,0
Autosomal recessive familial neurohypophyseal diabetes insipidus,no Modifier,0,0,0,0,0,0,0,0,0,0
Familial neurohypophyseal diabetes insipidus,no Modifier,0,0,0,0,0,0,0,0,0,0
autosomal dominant disorder,no Modifier,0,0,0,0,0,0,0,0,0,0
arginine vasopressin (AVP) deficiency,no Modifier,0,0,0,1.37377,0,0,0,0,0,0
neuronal damage,no Modifier,0,0,0,0,0,0,0,0,0,0
neurohypophyseal diabetes insipidus,no Modifier,0,0,0,0,0,0,0,0,0,0
deficiency of active AVP,no Modifier,0,0,0,1.37377,0,0,0,0,0,0
aniridia,no Modifier,0,0,0,0,0,0,0,0,0,0
aniridia,no Modifier,0,0,0,0,0,0,0,0,0,0
aniridia,no Modifier,0,0,0,0,0,0,0,0,0,0
aniridia,no Modifier,0,0,0,0,0,0,0,0,0,0
Knobloch syndrome,no Modifier,0,0,0,0,0,0,0,0,0,1.21605
midline scalp defect of the frontal region,no Modifier,0,0,0,0,0,0,0,0,0,0
Knobloch syndrome,no Modifier,0,0,0,0,0,0,0,0,0,1.21605
vitreoretinal degeneration,no Modifier,0,0,0,0,0,0,0,0,0,0
high myopia,no Modifier,0,0,0,0,0,0,0,0,0,0
cataract,no Modifier,0,0,0,0,0,0,0,0,0,0
telecanthus,no Modifier,0,0,0,0,0,0,0,0,0,0
hypertelorism,no Modifier,0,0,0,0,0,0,0,0,0,0
high-arched palate,no Modifier,0,0,0,0,0,0,0,0,0,0
defect of the anterior midline scalp,no Modifier,0,0,0,0,0,0,0,0,0,0
midline scalp defects,no Modifier,0,0,0,0,0,0,0,0,0,0
Pendred syndrome,no Modifier,0,0,0,0,0,0,0,0,0,1.21605
Pendred syndrome,no Modifier,0,0,0,0,0,0,0,0,0,1.21605
congenital sensorineural hearing loss,no Modifier,0,0,0,0,0,0,0,0,0,0
thyroid goiter,no Modifier,0,0,0,0,0,0,0,0,0,0
autosomal recessive disorder,no Modifier,0,0,0,0,0,0,0,0,0,0
congenital deafness,no Modifier,0,0,0,0,0,0,0,0,0,0
widened vestibular aqueduct,no Modifier,0,0,0,0,0,0,0,0,0,0
goiter,no Modifier,0,0,0,0,0,0,0,0,0,0
Pendred syndrome,no Modifier,0,0,0,0,0,0,0,0,0,1.21605
congenital hearing loss,no Modifier,0,0,0,0,0,0,0,0,0,0
inner ear morphological anomaly,no Modifier,0,0,0,0,0,0,0,0,0,0
thyroid goiter,no Modifier,0,0,0,0,0,0,0,0,0,0
familial adenomatous polyposis,no Modifier,0,0,0,0,0,0,0,0,0,0
tumors,no Modifier,0,0,0,0,0,0,0,0,0,0
FAP,no Modifier,0,0,0,0,0,0,0,0,0,0
familial adenomatous polyposis,no Modifier,0,0,0,0,0,0,0,0,0,0
sporadic colorectal cancers,no Modifier,0,0,1.12966,0,0,0,0,0,0,0
colorectal adenomas,no Modifier,0,0,0,0,0,0,0,0,0,0
FAP desmoids,no Modifier,0,0,0,0,0,0,0,0,0,0
tumors,no Modifier,0,0,0,0,0,0,0,0,0,0
tumors,no Modifier,0,0,0,0,0,0,0,0,0,0
VLCAD deficiency,no Modifier,0,0,0,1.37377,0,0,0,0,0,0
VLCAD deficiency,no Modifier,0,0,0,1.37377,0,0,0,0,0,0
cardiac disease,no Modifier,0,0,0,0,1.22993,0,0,0,0,0
hypertrophic cardiomyopathy,no Modifier,0,0,0,0,0,0,0,0,0,0
cardiac disease,no Modifier,0,0,0,0,1.22993,0,0,0,0,0
Lesch-Nyhan syndrome,no Modifier,0,0,0,0,0,0,0,0,0,1.21605
complete deficiency of hypoxanthine guanine phosphoribosyltransferase,no Modifier,0,0,0,1.37377,0,0,0,0,0,0
Lesch-Nyhan syndrome,no Modifier,0,0,0,0,0,0,0,0,0,1.21605
hyperphenylalaninemia,no Modifier,0,0,0,0,0,0,0,0,0,0
classical phenylketonuria,no Modifier,0,0,0,0,0,0,0,0,0,0
hemochromatosis,no Modifier,0,0,0,0,0,0,0,0,0,0
HFE deficiency,no Modifier,0,0,0,1.37377,0,0,0,0,0,0
hemochromatosis,no Modifier,0,0,0,0,0,0,0,0,0,0
G6PD deficiency,no Modifier,0,0,0,1.37377,0,0,0,0,0,0
G6PD deficiency,no Modifier,0,0,0,1.37377,0,0,0,0,0,0
G6PD deficiency,no Modifier,0,0,0,1.37377,0,0,0,0,0,0
malaria,no Modifier,0,0,0,0,0,0,0,0,0,0
G6PD deficiency,no Modifier,0,0,0,1.37377,0,0,0,0,0,0
Wiskott-Aldrich syndrome,no Modifier,0,0,0,0,0,0,0,0,0,1.21605
Wiskott-Aldrich syndrome,no Modifier,0,0,0,0,0,0,0,0,0,1.21605
WAS,no Modifier,0,0,0,0,0,0,0,0,0,0
adrenoleukodystrophy,no Modifier,0,0,0,0,0,0,1.14098,0,0,0
adrenomyeloneuropathy,no Modifier,0,0,0,0,0,0,0,0,0,0
adrenoleukodystrophy,no Modifier,0,0,0,0,0,0,1.14098,0,0,0
ALD,no Modifier,0,0,0,0,0,0,0,0,0,0
adrenomyeloneuropathy,no Modifier,0,0,0,0,0,0,0,0,0,0
AMN,no Modifier,0,0,0,0,0,0,0,0,0,0
ALD,no Modifier,0,0,0,0,0,0,0,0,0,0
AMN,no Modifier,0,0,0,0,0,0,0,0,0,0
ALD,no Modifier,0,0,0,0,0,0,0,0,0,0
AMN,no Modifier,0,0,0,0,0,0,0,0,0,0
ALD,no Modifier,0,0,0,0,0,0,0,0,0,0
AMN,no Modifier,0,0,0,0,0,0,0,0,0,0
ALD,no Modifier,0,0,0,0,0,0,0,0,0,0
AMN,no Modifier,0,0,0,0,0,0,0,0,0,0
Tay-Sachs disease,no Modifier,0,0,0,0,1.22993,0,0,0,0,0
TSD,no Modifier,0,0,0,0,0,0,0,0,0,0
Huntington disease,no Modifier,0,0,0,0,1.22993,0,0,0,0,0
HD,no Modifier,0,0,0,0,0,0,0,0,0,0
autosomal dominant neurodegenerative disorder,no Modifier,0,0,0,0,0,0,0,0,0,0
myotonic dystrophy,no Modifier,0,0,0,0,0,0,1.14098,0,0,0
muscular dystrophy,no Modifier,0,0,0,0,0,0,1.14098,1.09225,0,0
myotonic dystrophy,no Modifier,0,0,0,0,0,0,1.14098,0,0,0
DM,no Modifier,0,0,0,0,0,0,0,0,0,0
hemochromatosis,no Modifier,0,0,0,0,0,0,0,0,0,0
Li-Fraumeni syndrome,no Modifier,0,0,0,0,0,0,0,0,0,1.21605
autosomal dominant disorder,no Modifier,0,0,0,0,0,0,0,0,0,0
cancer,no Modifier,0,0,1.12966,0,0,0,0,0,0,0
cancers,no Modifier,0,0,1.12966,0,0,0,0,0,0,0
Li-Fraumeni syndrome,no Modifier,0,0,0,0,0,0,0,0,0,1.21605
cancer,no Modifier,0,0,1.12966,0,0,0,0,0,0,0
Li-Fraumeni syndrome,no Modifier,0,0,0,0,0,0,0,0,0,1.21605
seminoma,no Modifier,0,0,0,0,0,0,0,0,0,0
medulloblastoma,no Modifier,0,0,0,0,0,0,0,0,0,0
seminoma,no Modifier,0,0,0,0,0,0,0,0,0,0
Li-Fraumeni syndrome,no Modifier,0,0,0,0,0,0,0,0,0,1.21605
seminoma,no Modifier,0,0,0,0,0,0,0,0,0,0
medulloblastoma,no Modifier,0,0,0,0,0,0,0,0,0,0
tumorogenesis,no Modifier,0,0,0,0,0,0,0,0,0,0
phenylketonuria,no Modifier,0,0,0,0,0,0,0,0,0,0
Phenylketonuria,no Modifier,0,0,0,0,0,0,0,0,0,0
PKU,no Modifier,0,0,0,0,0,0,0,0,0,0
autosomal recessive human genetic disorder,no Modifier,0,0,0,0,0,0,0,0,0,0
deficiency of hepatic phenylalanine hydroxylase,no Modifier,0,0,0,1.37377,0,0,0,0,0,0
PKU,no Modifier,0,0,0,0,0,0,0,0,0,0
inborn error of amino-acid metabolism,no Modifier,0,0,0,0,0,0,0,0,0,0
PKU,no Modifier,0,0,0,0,0,0,0,0,0,0
molecular lesion,no Modifier,0,0,0,0,0,0,0,0,0,0
Duchenne muscular dystrophy,no Modifier,0,0,0,0,0,0,1.14098,1.09225,0,0
DMD,no Modifier,0,0,0,0,0,0,0,0,0,0
DMD,no Modifier,0,0,0,0,0,0,0,0,0,0
DMD,no Modifier,0,0,0,0,0,0,0,0,0,0
DMD,no Modifier,0,0,0,0,0,0,0,0,0,0
DMD,no Modifier,0,0,0,0,0,0,0,0,0,0
DMD,no Modifier,0,0,0,0,0,0,0,0,0,0
Familial adenomatous polyposis,no Modifier,0,0,0,0,0,0,0,0,0,0
FAP,no Modifier,0,0,0,0,0,0,0,0,0,0
colorectal cancer,no Modifier,0,0,1.12966,0,0,0,0,0,0,0
adenomatous polyposis coli,no Modifier,0,0,0,0,0,0,0,0,0,0
APC,no Modifier,0,0,0,0,0,0,0,0,0,0
familial adenomatous polyposis,no Modifier,0,0,0,0,0,0,0,0,0,0
FAP,no Modifier,0,0,0,0,0,0,0,0,0,0
Duchenne muscular dystrophy,no Modifier,0,0,0,0,0,0,1.14098,1.09225,0,0
Duchenne muscular dystrophy,no Modifier,0,0,0,0,0,0,1.14098,1.09225,0,0
DMD,no Modifier,0,0,0,0,0,0,0,0,0,0
glucose-6-phosphate dehydrogenase (G6PD) deficiency,no Modifier,0,0,0,1.37377,0,0,0,0,0,0
G6PD deficiency,no Modifier,0,0,0,1.37377,0,0,0,0,0,0
Norrie disease,no Modifier,0,0,0,0,1.22993,0,0,0,0,0
pseudoglioma,no Modifier,0,0,0,0,0,0,0,0,0,0
NDP,no Modifier,0,0,0,0,0,0,0,0,0,0
X-linked neurodevelopmental disorder,no Modifier,0,0,0,0,0,0,0,0,0,0
Wolman disease,no Modifier,0,0,0,0,1.22993,0,0,0,0,0
Wolman disease,no Modifier,0,0,0,0,1.22993,0,0,0,0,0
Wolman disease,no Modifier,0,0,0,0,1.22993,0,0,0,0,0
Wolman disease,no Modifier,0,0,0,0,1.22993,0,0,0,0,0
sporadic ovarian tumours,no Modifier,0,0,0,0,0,0,0,0,1.07443,0
autosomal dominant syndrome,no Modifier,0,0,0,0,0,0,0,0,0,1.21605
breast and ovarian cancer,no Modifier,0,0,1.12966,0,0,0,0,0,1.07443,0
tumours,no Modifier,0,0,0,0,0,0,0,0,0,0
tumour,no Modifier,0,0,0,0,0,0,0,0,0,0
ovarian cancers,no Modifier,0,0,1.12966,0,0,0,0,0,1.07443,0
tumours,no Modifier,0,0,0,0,0,0,0,0,0,0
ovarian cancers,no Modifier,0,0,1.12966,0,0,0,0,0,1.07443,0
Duchenne muscular dystrophy,no Modifier,0,0,0,0,0,0,1.14098,1.09225,0,0
muscular dystrophy,no Modifier,0,0,0,0,0,0,1.14098,1.09225,0,0
Duchenne muscular dystrophy,no Modifier,0,0,0,0,0,0,1.14098,1.09225,0,0
DMD,no Modifier,0,0,0,0,0,0,0,0,0,0
limb-girdle muscular dystrophy,no Modifier,0,0,0,0,0,0,1.14098,1.09225,0,0
myopathy,no Modifier,0,0,0,0,0,0,0,0,0,0
uniparental disomy,no Modifier,0,0,0,0,0,0,0,0,0,0
Kaposi sarcoma,no Modifier,0,0,0,0,0,0,0,0,0,0
T-cell lymphoma,no Modifier,0,0,0,0,0,0,0,0,0,0
Wiskott-Aldrich syndrome,no Modifier,0,0,0,0,0,0,0,0,0,1.21605
eczema,no Modifier,0,0,0,0,0,0,0,0,0,0
thrombocytopenia,no Modifier,0,0,0,0,0,0,0,0,0,0
Wiskott-Aldrich syndrome,no Modifier,0,0,0,0,0,0,0,0,0,1.21605
WAS,no Modifier,0,0,0,0,0,0,0,0,0,0
lymphadenopathy,no Modifier,0,0,0,0,0,0,0,0,0,0
splenomegaly,no Modifier,0,0,0,0,0,0,0,0,0,0
thrombocytopenia,no Modifier,0,0,0,0,0,0,0,0,0,0
WAS,no Modifier,0,0,0,0,0,0,0,0,0,0
Kaposi sarcoma,no Modifier,0,0,0,0,0,0,0,0,0,0
T-cell large cell lymphoma,no Modifier,0,0,0,0,0,0,0,0,0,0
Epstein-Barr virus,no Modifier,0,0,0,0,0,0,0,0,0,0
cytomegalovirus,no Modifier,0,0,0,0,0,0,0,0,0,0
human immunodeficiency virus,no Modifier,0,0,0,1.37377,0,0,0,0,0,0
HIV,no Modifier,0,0,0,0,0,0,0,0,0,0
Kaposi sarcoma,no Modifier,0,0,0,0,0,0,0,0,0,0
congenital immunodeficiency syndrome,no Modifier,0,0,0,1.37377,0,0,0,0,0,1.21605
Kaposi sarcoma,no Modifier,0,0,0,0,0,0,0,0,0,0
HIV,no Modifier,0,0,0,0,0,0,0,0,0,0
Kaposi sarcoma,no Modifier,0,0,0,0,0,0,0,0,0,0
Combined genetic deficiency of C6 and C7,no Modifier,0,0,0,1.37377,0,0,0,0,0,0
sub-total deficiency of C6 and C7,no Modifier,0,0,0,1.37377,0,0,0,0,0,0
C6 deficiency,no Modifier,0,0,0,1.37377,0,0,0,0,0,0
Langer-Giedion syndrome,no Modifier,0,0,0,0,0,0,0,0,0,1.21605
Langer-Giedion syndrome,no Modifier,0,0,0,0,0,0,0,0,0,1.21605
LGS,no Modifier,0,0,0,0,0,0,0,0,0,0
LGS,no Modifier,0,0,0,0,0,0,0,0,0,0
LGS,no Modifier,0,0,0,0,0,0,0,0,0,0
LGS,no Modifier,0,0,0,0,0,0,0,0,0,0
LGS,no Modifier,0,0,0,0,0,0,0,0,0,0
Friedreich ataxia,no Modifier,0,0,0,0,0,0,0,0,0,0
Frataxin deficiency,no Modifier,0,0,0,1.37377,0,0,0,0,0,0
Friedreich ataxia,no Modifier,0,0,0,0,0,0,0,0,0,0
FRDA,no Modifier,0,0,0,0,0,0,0,0,0,0
autosomal recessive cardiodegenerative and neurodegenerative disease,no Modifier,0,0,0,0,1.22993,0,0,0,0,0
mitochondrial iron accumulation,no Modifier,0,0,0,0,0,0,0,0,0,0
hypersensitivity to oxidative stress,no Modifier,0,0,0,0,0,0,0,0,0,0
FRDA,no Modifier,0,0,0,0,0,0,0,0,0,0
G6PD deficiency,no Modifier,0,0,0,1.37377,0,0,0,0,0,0
episodic hemolytic anemia,no Modifier,0,0,0,0,0,0,0,0,0,0
life-long hemolytic anemia,no Modifier,0,0,0,0,0,0,0,0,0,0
G6PD deficiency,no Modifier,0,0,0,1.37377,0,0,0,0,0,0
G6PD deficiency,no Modifier,0,0,0,1.37377,0,0,0,0,0,0
adenomatous polyposis coli,no Modifier,0,0,0,0,0,0,0,0,0,0
adenomatous polyposis coli,no Modifier,0,0,0,0,0,0,0,0,0,0
APC,no Modifier,0,0,0,0,0,0,0,0,0,0
glucose-6-phosphate dehydrogenase deficiency,no Modifier,0,0,0,1.37377,0,0,0,0,0,0
G6PD deficiency,no Modifier,0,0,0,1.37377,0,0,0,0,0,0
G6PD deficiency,no Modifier,0,0,0,1.37377,0,0,0,0,0,0
GALT deficiency,no Modifier,0,0,0,1.37377,0,0,0,0,0,0
GALT deficiency,no Modifier,0,0,0,1.37377,0,0,0,0,0,0
diastrophic dysplasia,no Modifier,0,0,0,0,0,0,0,0,0,0
diastrophic dysplasia,no Modifier,0,0,0,0,0,0,0,0,0,0
DTD,no Modifier,0,0,0,0,0,0,0,0,0,0
adrenoleukodystrophy protein deficiency,no Modifier,0,0,0,1.37377,0,0,1.14098,0,0,0
X-ALD,no Modifier,0,0,0,0,0,0,0,0,0,0
Inherited defects,no Modifier,0,0,0,0,0,0,0,0,0,0
peroxisomal disorder,no Modifier,0,0,0,0,0,0,0,0,0,0
X-linked adrenoleukodystrophy,no Modifier,0,0,0,0,0,0,1.14098,0,0,0
X-ALD,no Modifier,0,0,0,0,0,0,0,0,0,0
X-ALD,no Modifier,0,0,0,0,0,0,0,0,0,0
X-linked amelogenesis imperfecta,no Modifier,0,0,0,0,0,0,0,0,0,0
inherited dental abnormality,no Modifier,0,0,0,0,0,0,0,0,0,0
X-linked amelogenesis imperfecta,no Modifier,0,0,0,0,0,0,0,0,0,0
XAI,no Modifier,0,0,0,0,0,0,0,0,0,0
XAI,no Modifier,0,0,0,0,0,0,0,0,0,0
XAI,no Modifier,0,0,0,0,0,0,0,0,0,0
XAI disease,no Modifier,0,0,0,0,1.22993,0,0,0,0,0
XAI,no Modifier,0,0,0,0,0,0,0,0,0,0
HFE defect,no Modifier,0,0,0,0,0,0,0,0,0,0
G6PD deficiency,no Modifier,0,0,0,1.37377,0,0,0,0,0,0
malaria,no Modifier,0,0,0,0,0,0,0,0,0,0
Glucose-6-phosphate dehydrogenase (G6PD) deficiency,no Modifier,0,0,0,1.37377,0,0,0,0,0,0
enzymopathy,no Modifier,0,0,0,0,0,0,0,0,0,0
malaria,no Modifier,0,0,0,0,0,0,0,0,0,0
malaria,no Modifier,0,0,0,0,0,0,0,0,0,0
G6PD deficiency,no Modifier,0,0,0,1.37377,0,0,0,0,0,0
malaria,no Modifier,0,0,0,0,0,0,0,0,0,0
X-linked disorder,no Modifier,0,0,0,0,0,0,0,0,0,0
G6PD deficiency,no Modifier,0,0,0,1.37377,0,0,0,0,0,0
G6PD A-,no Modifier,0,0,0,0,0,0,0,0,0,0
malaria,no Modifier,0,0,0,0,0,0,0,0,0,0
malaria,no Modifier,0,0,0,0,0,0,0,0,0,0
enzyme deficiency,no Modifier,0,0,0,1.37377,0,0,0,0,0,0
G6PD deficiency,no Modifier,0,0,0,1.37377,0,0,0,0,0,0
Prader-Willi syndrome,no Modifier,0,0,0,0,0,0,0,0,0,1.21605
chromosome 15 anomaly,no Modifier,0,0,0,0,0,0,0,0,0,0
Prader-Willi syndrome,no Modifier,0,0,0,0,0,0,0,0,0,1.21605
PWS,no Modifier,0,0,0,0,0,0,0,0,0,0
PWS,no Modifier,0,0,0,0,0,0,0,0,0,0
PWS,no Modifier,0,0,0,0,0,0,0,0,0,0
PWS,no Modifier,0,0,0,0,0,0,0,0,0,0
phenylketonuria,no Modifier,0,0,0,0,0,0,0,0,0,0
hyperphenylalaninemias,no Modifier,0,0,0,0,0,0,0,0,0,0
phenylketonuria,no Modifier,0,0,0,0,0,0,0,0,0,0
hyperphenylalaninemia,no Modifier,0,0,0,0,0,0,0,0,0,0
Tay-Sachs disease,no Modifier,0,0,0,0,1.22993,0,0,0,0,0
TSD,no Modifier,0,0,0,0,0,0,0,0,0,0
pyoderma gangrenosum,no Modifier,0,0,0,0,0,0,0,0,0,0
C7 deficiency,no Modifier,0,0,0,1.37377,0,0,0,0,0,0
pyoderma gangrenosum,no Modifier,0,0,0,0,0,0,0,0,0,0
PG,no Modifier,0,0,0,0,0,0,0,0,0,0
systemic diseases,no Modifier,0,0,0,0,1.22993,0,0,0,0,0
congenital complement deficiencies,no Modifier,0,0,0,0,0,0,0,0,0,0
PG,no Modifier,0,0,0,0,0,0,0,0,0,0
C7 deficiency,no Modifier,0,0,0,1.37377,0,0,0,0,0,0
Deficiencies of C7,no Modifier,0,0,0,0,0,0,0,0,0,0
immunologic abnormalities,no Modifier,0,0,0,0,0,0,0,0,0,0
PG,no Modifier,0,0,0,0,0,0,0,0,0,0
PG,no Modifier,0,0,0,0,0,0,0,0,0,0
Emerin deficiency,no Modifier,0,0,0,1.37377,0,0,0,0,0,0
Emery-Dreifuss muscular dystrophy,no Modifier,0,0,0,0,0,0,1.14098,1.09225,0,0
X-linked Emery-Dreifuss muscular dystrophy,no Modifier,0,0,0,0,0,0,1.14098,1.09225,0,0
EDMD,no Modifier,0,0,0,0,0,0,0,0,0,0
neuromuscular diseases,no Modifier,0,0,0,0,1.22993,0,0,1.09225,0,0
EDMD,no Modifier,0,0,0,0,0,0,0,0,0,0
deficiency of emerin,no Modifier,0,0,0,1.37377,0,0,0,0,0,0
EDMD,no Modifier,0,0,0,0,0,0,0,0,0,0
melanoma,no Modifier,0,0,0,0,0,0,0,0,0,0
melanoma,no Modifier,0,0,0,0,0,0,0,0,0,0
melanoma,no Modifier,0,0,0,0,0,0,0,0,0,0
melanomas,no Modifier,0,0,0,0,0,0,0,0,0,0
familial neurohypophyseal diabetes insipidus,no Modifier,0,0,0,0,0,0,0,0,0,0
Familial neurohypophyseal diabetes insipidus,no Modifier,0,0,0,0,0,0,0,0,0,0
FNDI,no Modifier,0,0,0,0,0,0,0,0,0,0
deficiency of the hormone arginine vasopressin,no Modifier,0,0,0,1.37377,0,0,0,0,0,0
FNDI,no Modifier,0,0,0,0,0,0,0,0,0,0
FNDI,no Modifier,0,0,0,0,0,0,0,0,0,0
Machado-Joseph disease,no Modifier,0,0,0,0,1.22993,0,0,0,0,0
MJD,no Modifier,0,0,0,0,0,0,0,0,0,0
neurodegenerative disorders,no Modifier,0,0,0,0,0,0,0,0,0,0
progressive cerebellar ataxia,no Modifier,0,0,0,0,0,0,0,0,0,0
spinocerebellar ataxia type 3,no Modifier,0,0,0,0,0,0,0,0,0,0
SCA3,no Modifier,0,0,0,0,0,0,0,0,0,0
MJD,no Modifier,0,0,0,0,0,0,0,0,0,0
degeneration of certain brain areas,no Modifier,0,0,0,0,0,0,0,0,0,0
solid tumors,no Modifier,0,0,0,0,0,0,0,0,0,0
alveolar rhabdomyosarcoma,no Modifier,0,0,0,0,0,0,0,0,0,0
Myotonia levior,no Modifier,0,0,0,0,0,0,0,0,0,0
chloride channel disorder,no Modifier,0,0,0,0,0,0,0,0,0,0
dominant non-dystrophic myotonias,no Modifier,0,0,0,0,0,0,0,0,0,0
Dominant myotonia congenita,no Modifier,0,0,0,0,0,0,0,0,0,0
Thomsens disease,no Modifier,0,0,0,0,1.22993,0,0,0,0,0
dominant myotonias,no Modifier,0,0,0,0,0,0,0,0,0,0
myotonia levior,no Modifier,0,0,0,0,0,0,0,0,0,0
myotonia,no Modifier,0,0,0,0,0,0,0,0,0,0
Thomsens disease,no Modifier,0,0,0,0,1.22993,0,0,0,0,0
muscle hypertrophy,no Modifier,0,0,0,0,0,0,0,0,0,0
myotonia levior,no Modifier,0,0,0,0,0,0,0,0,0,0
Thomsens disease,no Modifier,0,0,0,0,1.22993,0,0,0,0,0
Thomsens disease,no Modifier,0,0,0,0,1.22993,0,0,0,0,0
recessive myotonia,no Modifier,0,0,0,0,0,0,0,0,0,0
cholesterol acyltransferase deficiency,no Modifier,0,0,0,1.37377,0,0,0,0,0,0
fish-eye disease,no Modifier,0,0,0,0,1.22993,0,0,0,0,0
Classic (complete) lecithin  cholesterol acyltransferase (LCAT) deficiency,no Modifier,0,0,0,1.37377,0,0,0,0,0,0
Fish-eye disease,no Modifier,0,0,0,0,1.22993,0,0,0,0,0
partial LCAT deficiency,no Modifier,0,0,0,1.37377,0,0,0,0,0,0
atherosclerotic cardiovascular disease,no Modifier,0,0,0,0,1.22993,0,0,0,0,0
LCAT deficiency,no Modifier,0,0,0,1.37377,0,0,0,0,0,0
classic LCAT deficiency,no Modifier,0,0,0,1.37377,0,0,0,0,0,0
Fish-eye disease,no Modifier,0,0,0,0,1.22993,0,0,0,0,0
complete or partial LCAT deficiency,no Modifier,0,0,0,1.37377,0,0,0,0,0,0
atherosclerosis,no Modifier,0,0,0,0,0,0,0,0,0,0
classic LCAT deficiency,no Modifier,0,0,0,1.37377,0,0,0,0,0,0
Fish-eye disease,no Modifier,0,0,0,0,1.22993,0,0,0,0,0
atherosclerosis,no Modifier,0,0,0,0,0,0,0,0,0,0
adenomatous polyps of the colon and rectum,no Modifier,0,0,0,0,0,0,0,0,0,0
colorectal cancer,no Modifier,0,0,1.12966,0,0,0,0,0,0,0
attenuated adenomatous polyposis coli,no Modifier,0,0,0,0,0,0,0,0,0,0
AAPC,no Modifier,0,0,0,0,0,0,0,0,0,0
AAPC,no Modifier,0,0,0,0,0,0,0,0,0,0
colorectal polyps,no Modifier,0,0,0,0,0,0,0,0,0,0
colorectal cancer,no Modifier,0,0,1.12966,0,0,0,0,0,0,0
aspartylglucosaminuria,no Modifier,0,0,0,0,0,0,0,0,0,0
AGU,no Modifier,0,0,0,0,0,0,0,0,0,0
Aspartylglucosaminuria,no Modifier,0,0,0,0,0,0,0,0,0,0
AGU,no Modifier,0,0,0,0,0,0,0,0,0,0
X-linked adrenoleukodystrophy,no Modifier,0,0,0,0,0,0,1.14098,0,0,0
X-linked adrenoleukodystrophy,no Modifier,0,0,0,0,0,0,1.14098,0,0,0
ALD,no Modifier,0,0,0,0,0,0,0,0,0,0
ALD,no Modifier,0,0,0,0,0,0,0,0,0,0
ALD,no Modifier,0,0,0,0,0,0,0,0,0,0
ALD,no Modifier,0,0,0,0,0,0,0,0,0,0
abnormalities in the vision blindness genes,no Modifier,0,0,0,0,0,0,0,0,0,0
Genetic hemochromatosis,no Modifier,0,0,0,0,0,0,0,0,0,0
GH,no Modifier,0,0,0,0,0,0,0,0,0,0
infectious diseases,no Modifier,0,0,0,0,1.22993,0,0,0,0,0
genetic disorders,no Modifier,0,0,0,0,0,0,0,0,0,0
anemia,no Modifier,0,0,0,0,0,0,0,0,0,0
Lesch-Nyhan syndrome,no Modifier,0,0,0,0,0,0,0,0,0,1.21605
Lesch-Nyhan syndrome,no Modifier,0,0,0,0,0,0,0,0,0,1.21605
Familial Mediterranean fever,no Modifier,0,0,0,0,0,0,0,0,0,0
Familial Mediterranean fever,no Modifier,0,0,0,0,0,0,0,0,0,0
FMF,no Modifier,0,0,0,0,0,0,0,0,0,0
recessively inherited disorder,no Modifier,0,0,0,0,0,0,0,0,0,0
serosal inflammation,no Modifier,0,0,0,0,0,0,0,0,0,0
Renal amyloidosis,no Modifier,0,0,0,0,0,0,0,0,0,0
FMF,no Modifier,0,0,0,0,0,0,0,0,0,0
renal amyloidosis,no Modifier,0,0,0,0,0,0,0,0,0,0
arthritis,no Modifier,0,0,0,0,0,0,0,0,0,0
HD,no Modifier,0,0,0,0,0,0,0,0,0,0
colorectal polyps,no Modifier,0,0,0,0,0,0,0,0,0,0
familial adenomatous polyposis,no Modifier,0,0,0,0,0,0,0,0,0,0
FAP,no Modifier,0,0,0,0,0,0,0,0,0,0
colorectal polyps,no Modifier,0,0,0,0,0,0,0,0,0,0
polyps,no Modifier,0,0,0,0,0,0,0,0,0,0
polyps,no Modifier,0,0,0,0,0,0,0,0,0,0
colorectal polyps,no Modifier,0,0,0,0,0,0,0,0,0,0
Duchenne/Becker muscular dystrophy,no Modifier,0,0,0,0,0,0,1.14098,1.09225,0,0
Duchenne and Becker muscular dystrophy,no Modifier,0,0,0,0,0,0,1.14098,1.09225,0,0
DMD,no Modifier,0,0,0,0,0,0,0,0,0,0
BMD,no Modifier,0,0,0,0,0,0,0,0,0,0
DMD,no Modifier,0,0,0,0,0,0,0,0,0,0
DMD defects,no Modifier,0,0,0,0,0,0,0,0,0,0
galactosemia,no Modifier,0,0,0,0,0,0,0,0,0,0
Gaucher disease,no Modifier,0,0,0,0,1.22993,0,0,0,0,0
Gaucher disease,no Modifier,0,0,0,0,1.22993,0,0,0,0,0
GD,no Modifier,0,0,0,0,0,0,0,0,0,0
lysosomal storage disorder,no Modifier,0,0,0,0,0,0,0,0,0,0
Prader-Willi syndrome,no Modifier,0,0,0,0,0,0,0,0,0,1.21605
Prader-Willi syndrome,no Modifier,0,0,0,0,0,0,0,0,0,1.21605
PWS,no Modifier,0,0,0,0,0,0,0,0,0,0
PWS,no Modifier,0,0,0,0,0,0,0,0,0,0
hypothalamic abnormalities,no Modifier,0,0,0,0,0,0,0,0,0,0
cerebrotendinous xanthomatosis,no Modifier,0,0,0,0,0,0,0,0,0,0
genetic disease,no Modifier,0,0,0,0,1.22993,0,0,0,0,0
cerebrotendinous xanthomatosis,no Modifier,0,0,0,0,0,0,0,0,0,0
CTX,no Modifier,0,0,0,0,0,0,0,0,0,0
Abnormalities in the HDL,no Modifier,0,0,0,0,0,0,0,0,0,0
CTX,no Modifier,0,0,0,0,0,0,0,0,0,0
genetic defect,no Modifier,0,0,0,0,0,0,0,0,0,0
CTX,no Modifier,0,0,0,0,0,0,0,0,0,0
Papillon-Lefevre syndrome,no Modifier,0,0,0,0,0,0,0,0,0,1.21605
Papillon-Lefevre syndrome,no Modifier,0,0,0,0,0,0,0,0,0,1.21605
PLS,no Modifier,0,0,0,0,0,0,0,0,0,0
autosomal recessive disorder,no Modifier,0,0,0,0,0,0,0,0,0,0
palmoplantar hyperkeratosis,no Modifier,0,0,0,0,0,0,0,0,0,0
periodontitis,no Modifier,0,0,0,0,0,0,0,0,0,0
PLS,no Modifier,0,0,0,0,0,0,0,0,0,0
PLS,no Modifier,0,0,0,0,0,0,0,0,0,0
PLS,no Modifier,0,0,0,0,0,0,0,0,0,0
palmoplantar hyperkeratosis,no Modifier,0,0,0,0,0,0,0,0,0,0
periodontitis,no Modifier,0,0,0,0,0,0,0,0,0,0
PLS,no Modifier,0,0,0,0,0,0,0,0,0,0
Lesch-Nyhan syndrome,no Modifier,0,0,0,0,0,0,0,0,0,1.21605
deficiency of hypoxanthine-guanine phosphoribosyltransferase,no Modifier,0,0,0,1.37377,0,0,0,0,0,0
Lesch-Nyhan syndrome,no Modifier,0,0,0,0,0,0,0,0,0,1.21605
Lesch-Nyhan syndrome,no Modifier,0,0,0,0,0,0,0,0,0,1.21605
Denys-Drash syndrome,no Modifier,0,0,0,0,0,0,0,0,0,1.21605
Denys-Drash syndrome,no Modifier,0,0,0,0,0,0,0,0,0,1.21605
nephropathy,no Modifier,0,0,0,0,0,0,0,0,0,0
genital abnormalities,no Modifier,0,0,0,0,0,0,0,0,0,0
Wilms tumor,no Modifier,0,0,0,0,0,0,0,0,0,0
renal failure,no Modifier,0,0,0,0,0,0,0,0,0,0
prolidase deficiency,no Modifier,0,0,0,1.37377,0,0,0,0,0,0
prolidase deficiency,no Modifier,0,0,0,1.37377,0,0,0,0,0,0
autosomal recessive disorder,no Modifier,0,0,0,0,0,0,0,0,0,0
iminodipeptiduria,no Modifier,0,0,0,0,0,0,0,0,0,0
skin ulcers,no Modifier,0,0,0,0,0,0,0,0,0,0
mental retardation,no Modifier,0,0,0,0,0,0,0,0,0,0
prolidase deficiency,no Modifier,0,0,0,1.37377,0,0,0,0,0,0
isolated aniridia,no Modifier,0,0,0,0,0,0,0,0,0,0
isolated aniridia,no Modifier,0,0,0,0,0,0,0,0,0,0
aniridia,no Modifier,0,0,0,0,0,0,0,0,0,0
X-linked Emery-Dreifuss muscular dystrophy,no Modifier,0,0,0,0,0,0,1.14098,1.09225,0,0
Emery-Dreifuss muscular dystrophy,no Modifier,0,0,0,0,0,0,1.14098,1.09225,0,0
EMD,no Modifier,0,0,0,0,0,0,0,0,0,0
X-linked EMD,no Modifier,0,0,0,0,0,0,0,0,0,0
ankle contractures,no Modifier,0,0,0,0,0,0,0,0,0,0
muscle weakness,no Modifier,0,0,0,0,0,0,0,0,0,0
Duchenne and the milder Becker muscular dystrophies,no Modifier,0,0,0,0,0,0,0,1.09225,0,0
dystrophic syndrome,no Modifier,0,0,0,0,0,0,0,0,0,1.21605
Duchenne/Becker muscular dystrophy,no Modifier,0,0,0,0,0,0,1.14098,1.09225,0,0
DMD,no Modifier,0,0,0,0,0,0,0,0,0,0
myopathies,no Modifier,0,0,0,0,0,0,0,0,0,0
Emery Dreifuss muscular dystrophy,no Modifier,0,0,0,0,0,0,1.14098,1.09225,0,0
hexosaminidase A deficiency,no Modifier,0,0,0,1.37377,0,0,0,0,0,0
Tay-Sachs disease,no Modifier,0,0,0,0,1.22993,0,0,0,0,0
TSD,no Modifier,0,0,0,0,0,0,0,0,0,0
Phenylketonuria,no Modifier,0,0,0,0,0,0,0,0,0,0
PKU,no Modifier,0,0,0,0,0,0,0,0,0,0
deficiency of the enzyme phenylalanine hydroxylase,no Modifier,0,0,0,1.37377,0,0,0,0,0,0
PKU,no Modifier,0,0,0,0,0,0,0,0,0,0
Macular dystrophy,no Modifier,0,0,0,0,0,0,1.14098,0,0,0
autosomal dominant retinitis pigmentosa,no Modifier,0,0,0,0,0,0,0,0,0,0
macular dystrophy,no Modifier,0,0,0,0,0,0,1.14098,0,0,0
visual loss,no Modifier,0,0,0,0,0,0,0,0,0,0
central scotoma,no Modifier,0,0,0,0,0,0,0,0,0,0
atrophy of the retinal pigment epithelium,no Modifier,0,0,0,0,0,0,0,0,0,0
choriocapillaris of the macula,no Modifier,0,0,0,0,0,0,0,0,0,0
macular dystrophy,no Modifier,0,0,0,0,0,0,1.14098,0,0,0
cone dysfunction,no Modifier,0,0,0,0,0,0,0,0,0,0
